Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 2
1 [ . . . . : . . . . 1 . . . . : . . . . 2 . . . . : ] 253
batch____ bits E-value N 100.0% 1:253 MRILLSNDDGVHAPGIQTLAKALREFADVQVVAPDRNRSGASNSLTLESSLRTFTFENGDIAVQMGTPTDCVYLGVNALMRPRPDIVVSGINAGPNLGDDVIYSGTVAAAMEGRHLGFPALAVSLDGHKHYDTAAAVTCSILRALCKEPLRTGRILNINVPDLPLDQIKGIRVTRCGTRHPADQVIPQQDPRGNTLYWIGPPGGKCDAGPGTDFAAVDEGYVSITPLHVDLTAHSAQDVVSDWLNSVGVGTQW
1 UniRef50_A1ASL7 5'-nucleotidase surE n=3 Ta... 337 3e-91 1 47.5% 1:244 1:246 MHIMVTNDDGIQAPGIQALASALRVLGEVTVVAPDRERSAVGHALTLNSPLRVFELRD-GFYAVDGTPTDCVNMGIHSLLPFRPDLIVSGINHGANLGDDVTYSGTVAAAIEATLMGIPAIAVSLATQehFPEAAQIAVRVARQVLSNGLPEDTFLNVNVPDCPAEEIRPPLVTRQGKRSFVGNVIDKTDPRGRKYYWIGSGEADFNDYEGTDFHAINRKHVSITPLHLDLTNYASMKVITTWV---------
2 UniRef50_A0KGH8 5'-nucleotidase surE n=8 Ta... 333 4e-90 1 62.0% 1:245 1:250 MRILVSNDDGVHAEGIRALSEALTACGEVIVVAPDRNRSGASHSLTLEVPLRVTRLGETGfyAVKGTPTDCVHLAVNELVRPEPDMVVAGINHGANLGDDVIYSGTVAAATEGRHLGFPSLAISLVGKTHFATAAHYAAQLVKGMMVHPLPADQILNVNVPDLPLDQIKGIRVTRLGNRHRAESVICSEDPRGQPIYWIGPPGSQQDAGEGTDFAAIEQGYVSITPLTIDMTAYSSLAGLGAWLD--------
3 UniRef50_A5F9D9 5'-nucleotidase surE n=205 ... 332 5e-90 1 55.3% 1:246 14:259 MKILLSNDDGVYAQGIHALADALRDLAEIVIVAPDRNRSGASNSLTLEHPLRVSQIAENT-YSVQGTPTDCVHFALNELMKDapDLVLSGINHGANLGDDVLYSGTVAAAMEGHFLGVQSIAFSLAGTTHFASAAHFVRQLVEQHLANPIPTNRLLNVNIPDRPLELIQGIEVTRLGARHHAESMIKQKDPRGHDIYWLGPPGKEQDAGPGTDFHAIERGWVSLTPLQVDLTAHESLRSMDHWLKE-------
4 UniRef50_B0TAY4 5'-nucleotidase surE n=10 T... 332 5e-90 1 46.7% 1:246 1:252 MRILLTNDDGIHAPGIHALWRIFDDWADIFVVAPDTERSATGHGITVHQPLRVEKLshCHGWAVNGTPADCVKLAMEELLAEPPHIVISGINRGPNLGTDVLYSGTVSAAMEGVIYGVPSIAVSVTGwaDYTVAAETTRLLCEKLVARGLTPDTFLNVNVPDLPRERIAGIQVTKLGSRRYQNIFDKRTDPRGRTYYWMAGEVHDVDAGEGTDISAVNAGAISVTPIHFDLTNYSLIQEVSDWLGG-------
5 UniRef50_A9N2D0 Exopolyphosphatase n=110 Ta... 330 3e-89 1 92.1% 1:253 1:253 MRILLSNDDGVHAPGIQTLAKALREFADVQVVAPDRNRSGASNSLTLESSLRTFTFDNGDIAVQMGTPTDCVYLGVNALMRPRPDIVVSGINAGPNLGDDVIYSGTVAAAMEGRHLGFPALAVSLNGYQHYDTAAAVTCALLRGLSREPLRTGRILNVNVPDLPLAQIKGIRVTRCGSRHPADKVIPQEDPRGNTLYWIGPPGDKYDAGPDTDFAAVDEGYVSVTPLHVDLTAHSAHDVVSDWLDSVGVGTQW
6 UniRef50_A5UHI7 5'-nucleotidase surE n=18 T... 329 4e-89 1 56.9% 1:246 1:245 MRILVSNDDGFHAEGIQVLATELRKIAEVIVVAPDRNRSAASSSLTLVEPLRPRHLDNGD-YCVNGTPADCVYLALNGFLSGQVDLVVSGINAGCNMGDDTIYSGTLAAALEGRHLGLPAIAVSLDGRQHYETAARVVCDLIPKLHHQLLNPREIININVPDLPFEELKGYKVCRLGYRASSAEVIKQKDPRDETIYWIGPSALPEDESEGTDFYAVKNGYVSITPIQADLTAYHSLLSLQNWLEQ-------
7 UniRef50_B3QYH6 Stationary-phase survival p... 329 8e-89 1 36.0% 2:243 25:271 -KILVTNDDGIDAEGIRVLAQSMQRIGDVTVVAPASPQSGMSHAMTLGRPLRIQKVYKNkgYSVSGTPVDCVKVAMTHILKDRPDLVVSGINYGSNTAINILYSGTIGAAVEGRIYEIPSIAFSlyENADFSYAGKVARQIAKKVLEKGLPPRTLLSVNIPNVPESDIQGIVVTRQGRSCWQESMIEHHDPYGQPYYWLNGMMALYDDKLTDDEYAIRHNYVSVTPLRFDLTNYDFMESLTSW----------
8 UniRef50_Q0AXU4 5'-nucleotidase surE n=1 Ta... 328 1e-88 1 42.3% 1:248 1:254 MRILLTNDDGIHARGIQALIGELGSIAELFVAAPDRERSGTGHSITVFDPIKVIKAKLAGiwVIGGTPVDCVKLASSKLVGDNIDLVVSGINHGPNLGTDVLYSGTVSAAVEGVIMGSPSIAVSLNsdTDFSFAARFTRQVIQNLFKNGMEKKTLLNINIPYLCPQDIKGIRITRLGVRNYENLFEERHDPRGNTYFWMGGGVLEEPQEEDSDVNAVQHSYISITPIHFDLTDYHLVEQYRKSFSQFS-----
9 UniRef50_C6M3Z2 5'/3'-nucleotidase SurE n=2... 320 3e-86 1 45.6% 1:248 1:249 MNILISNDDGYLAPGIAILARVAAEFANVRVVAPERDRSGVSNSLTLDRPLQIKEASN-GFYYVSGTPTDCIHVGQHALPDFKPDLVLSGINNGANMGDDTLYSGTVAAATEAYLMGIPAIAFSLNDSryWKTAEKSVWMLLEYLLKNPPKEPILWNINIPAVMPEDIQGIKITRLGRRHHEQSIVPMHNPRGEPIYWIGPVGNISDQEKGTDFGECEAGFITITPLQIDLTAYNQLQSVNEFWQGIK-----
10 UniRef50_Q8RA90 5'-nucleotidase surE n=2 Ta... 320 4e-86 1 41.9% 3:243 6:251 --VLLTNDDGVQAKGILYLAEYLKENgdVVVVAPEKERSAISHAITLHKPLrvREEENLRIYAINGTPSDCVKMGIEVVMEKNPDIIISGINNGLNMGTDILYSGTVSAAIEGALYGIPALAVSLEEDGDFEEQRMYikKLIEKVLEEGLPKNTLLNVNIPDF-RKGINGIRITILGKRIYTETFQKNYDPRGKEYYWMAGKISEIDNDERTDIVSVKKGYISITPIHFDLTDYEAVKKLSSW----------
11 UniRef50_A0M5L6 5'-nucleotidase surE n=30 T... 319 6e-86 1 37.8% 3:243 8:256 --ILVTNDDGITAPGIRTLVEVMKELGDVIVVAPDSPQSGMGHAITISDTLFCEQVTIKESysCSGTPADCVKIATQEILHRKPDLCVSGINHGSNSSINVIYSGTMSAAVEAGIEGIPAIGFSLLDYsdFEPTRKFIKTITKNVLKNGLPIGVVLNVNIPKLKEAEIKGIKVCRQANAHWEEEFDKRTNPQGREYYWLTGKFVNKDEGKDTDEKALEEGYVSVVPVQFDLTAHHFIKDLSSW----------
12 UniRef50_A3J2F7 Acid phosphatase, survival ... 317 2e-85 1 35.7% 3:243 6:253 --ILVTNDDGIIAPGIRALISVMKELGEVVVVAPDSPQSAMGHAITINDTLKLTKveVEKEYSCSGTPVDCVKIAVNEILKRKPDLCVSGVNHGSNSSINVIYSGTMSAAVEAGIEGIPAIGFSLLDYsnFEPIKSHIKKIASEVLKNGLPEGVILNVNFPKLAKEDIKGTKICRQAKAMWQEEFDKRTNPHGKDYYWLTGKFVNLDKGTDTDEWALENGYISIVPVQFDLTAHHAMQQLNSW----------
13 UniRef50_B2A4J5 5'-nucleotidase surE n=10 T... 317 3e-85 1 39.9% 1:243 1:255 MKVLLTNDDGIYAPGIFAMAKEirDEFEAVVVAPDREQSATGHAITVHKPLRVNNVkeIPFYSVNGTPSDCVKLAVESVMDEKPDLVISGINRGANLGTDVLYSGTVSGAMEAAILNIKSIAVSlyDYEDYSTAASYTAYIANIIKDNpfENGTLLNVNVPAVEANQLKGVKITRQGFRQYENIFEKRFDPRGKAYYWMAGKVIEDTSDIKTDVASVKENYVSVTPIKYDLTDYNLYNSLSNW----------
14 UniRef50_C5TPI4 5'/3'-nucleotidase SurE n=6... 314 2e-84 1 45.3% 1:247 1:248 MNILISNDDGYLAPGLAVLARVCAEFANVRVVAPERDRSGVSNSLTLDRPLQLKQAEN-GFYYVNGTPTDCIHVGQHALADFKPDLVLSGINNGANMGDDTLYSGTVAAATEAYLMGIPAIAFSLADsrYWETAEKAAWILLSYFLKRPISEPILWNINIPAVAPEDIQGIKITRLGRRHHEQSIVPMYNPRGEQIYWIGPVGDVSDSEEGTDFGECASGFITITPLQVDLTAYGQMEQTASFWSEI------
15 UniRef50_A8UY79 Stationary phase survival p... 314 2e-84 1 41.8% 3:241 4:245 --ILVTNDDGYFSEGIKALREALKPLGRVVVVAPDRNLSGVGHSLTFTMPLRMRKVDEDFYTVIGGTPADCIHLGYHVILeeKPDLVCAGINEGPNLGEDITYSGTVSGAMEGRILGIPSVAFSAFGREefSEVAKSCRRVVEKVLEVGMPEDTYLNVNVPNLSSEEVKGIRLTRQGKRDYREKVFRYITPYGEPLYWIAAEEFGWSPEEGTDYWAVINGYVSVTPLQLDLTNYGAFKDIK------------
16 UniRef50_C1SH37 5'/3'-nucleotidase SurE n=1... 314 2e-84 1 40.5% 1:242 1:247 MRILLANDDGIYSEGIYALYKKLTEIADVTVVAPITEQSAVGHAITVADPLRvyKFGEFFGYGIKGSPADCVKIAISDIMDRKPDLVVSGINHGANLATNVIYSGTVSAATEGAMMGVRSVAVSLATKedFTTSAEIGAYFAKYMYSSSLPDNAVLNINVPALSKERIKGWRFARQGNSKYLDTFAKRTDPRGGSYYWLTGEKVEIDVTPESDEYMVENGYVSVTPLMFDMTDYRMYDQLKD-----------
17 UniRef50_B8FC91 5'-nucleotidase surE n=1 Ta... 314 2e-84 1 38.7% 1:243 1:248 MHILVTNDDGIHHPGLAALRDGLARDHRVQVVAPDRERSAIAHAITLLTPLRatNGNGIPSWAVNGTPADCVKLGVLELLGEKPDLVVSGINPGPNVGVNLNYSGTVSAAREAALLGIPAIAVSVSNptHFSDAARFMQDLVADVAERGLPKGVFLNVNLPDVPMEEIAGVRICRQGIARLEEAFHVRKDPRNQPYYWQGSETQLFGESPDEDGVALRENCIAVTPVQCDMTDYGFLNQLKEW----------
18 UniRef50_Q1Q1F9 Similar to acid phosphatase... 313 2e-84 1 40.3% 1:243 16:264 MQILLTNDDGIYAPGIASLKHYIQDLGTVTVVAPDIEQSGVGHSITFNQPLRIRKVheFIGYGVNGSPADCVKLAVNEIMREKPDIVISGLNMGANVGIHILYSGTVAAAVEATVMGFSSIAVSFEITEHYDdtADVAKGIIQRILSHNLPKNLLLNVNIPAIPPDQIKGIKITHQFTQDFKEVFQKRIDPSGRAYYWLTGADKSKYHEEGTDLSALRDGYISITPLRYDRTDYQHHKIIEGW----------
19 UniRef50_D0JBF9 Acid phosphatase, stationar... 313 3e-84 1 32.8% 3:243 7:255 --ILVTNDDGIIAPGIRALVQSMNSLGDVYVVAPNKPQSGVGHAITMDTVLYCDSigNQKEWECSGTPVDCVKLAIDKILPKKPDICVSGINHGSNSSINIMYSGTISAVIEASIEGIPSVGFSldWNADFEPSKKYVYQIVKKILYNPIPEKIilNVNIPKLKKEQIKGIKICRQAGSKWKESFDKRSNPKGRTYYWLGGDFVNFDEKIDTDEWALKNGYISIVPIQFDLTNYPILNILKSW----------
20 UniRef50_Q1D402 5'-nucleotidase surE n=3 Ta... 312 8e-84 1 41.3% 2:243 7:249 -RILVSNDDGYFSEGLQALVEAVSPLGEVWVVAPDREQSAASHAISLHRPLRIKEVRE-RWFAVDGTPADCAYLAINHLldDRPVLMVSGINHGANLAEDIMYSGTVAAAMEGALLGVPAIAFSLVARRNFDFaaRFARSLVSSALSRPLPPRMLLNVNIP--GGVEPEGYVVTRQGRHSYGFEVVENEDPRGRKYYWIGGSDYQHEDIPGSDCNAvrDKRVSVTPLHFELTDHGRLPDLSGW----------
21 UniRef50_A7HLM0 5'-nucleotidase surE n=13 T... 310 4e-83 1 36.2% 1:246 1:254 MNILLVNDDGVTAPGILCAARYLSKEHYVVVSAPESEQSAVGHGITLRFPLWARKlePFEMYAVSGTPADCVKIGLDVIYKDkpDVVISGINRGENLGTDVVYSGTVSGALEGAIAGVPSIAISVADFKdyETGARFLLNFLKEFDVKRIPRFTALNINVPSVPYEQIKGWKLTRQSKRRYEDYFEKRIDPYGKDYYWMLGDIIEDDPDPKADYKALKEGYISVTPITIFMTNEELLKELEGIYGD-------
22 UniRef50_B8CWH0 5'-nucleotidase surE n=1 Ta... 308 1e-82 1 41.3% 1:247 1:255 MNVLLTNDDGVYAEGIFILASYLVSAGhvVVSAPDRERSATGHAITISYPLRAYKigEIDVYKIDGTPADCVKLGVEKLAGFKPDIIISGINDGPNLGYDVLYSGTVSAAIEGWMMGYTSIAVSLNSNghFKTGADFIVRLLNNFDFLSLDQKMLLNINIPDLPGEKINGIKITKLGKSLYEDSFEKRFDPMGKPYYWLTGNNVDNNIHDSTDIWAIKNNYISITPLKIDLTDLSQIDILNHNLNNL------
23 UniRef50_Q30YV9 5'-nucleotidase surE n=3 Ta... 308 1e-82 1 38.1% 1:252 1:257 MFIALTNDDGIQAPGLRAMYKALKEAGhvQVVAPVTEQSAVGHAVTIALPLRVKIFAENGfmGVYGTPTDCVKLGLNALLDKKPDIVVSGINAGANVGPDILYSGTVSAATEAAHMGYPSLAVSYDnpDDIAAHARFAVEIMESMPWQSLPPRCVLNLNLPDVPMQQCKGLTLCPQTRAVWKDWYDHRTDPRGNSYWWLNGIIPPETVAEGTDRDMLTRGYATLTPLRFDFTDRETLARLQQNMDRQRQGSE-
24 UniRef50_A6TRH0 5'-nucleotidase surE n=1 Ta... 307 2e-82 1 38.7% 1:243 1:250 MRILVTNDDGIFAEGIYVLAKSLQDVGEVIVVAPNTERSAVGHGITMHHPLRMAGvtSIEAYSVNGTPADCIKIAIEVLldRKPTVVVSGINNGPNLGTDVLYSGTVSAAVEAAILDLPSIAVSMATSkqYNHAAEFICKLLSNTLHIEELSDTIINVNYPTIAYSEIKGVKVTNLGIRKYENAFIERLDPRGNAYYWISGKAMELAQDHESDVQAINDNYISITPIHFDLTHFKSFKKLKNL----------
25 UniRef50_A3ZQ54 Survival protein SurE n=2 T... 307 3e-82 1 35.4% 1:243 1:248 MEILLTNDDGIYAPGLAAMERQLQKLGNVTVVAPATEQSGVGHSITFLSPLVCKEAYDgrGYAVEGSPADCVKIGVFEFCKKRPDLIVSGINGGLNAGINVLYSGTVAAAIEGAFFGITSVAVSLEWDEnfDVAALKGREIIEKILAQKGEPAQLFNLNFPTAALRKKSIVQVVPMGLARYGEHFIKRKDPRGRDYYWSTGDPKPEHGSEETDLSALEKGDITLTPLHFNLTESAYLDRMKSW----------
26 UniRef50_B8FYS8 5'-nucleotidase surE n=2 Ta... 306 5e-82 1 43.3% 1:245 1:245 MHILLTNDDGYFAPGLQTLYTTLAEAgdVFIVAPDSQKSATGHSITLFEPLFITklDRGTGYAVSGKPADCVKLAIQGSIIPKPDLVISGINNGPNLGTDVFYSGTVSAAMEGVLLGVPAIAVSLASFsdYKPAAQFVALSLPKLRLGPG----LININIPPLPEKEWKGVRVTKLGKAVYENVFEHRQAPYGRDYYWQAGT-VSPEVDQETDLYAVQEGYVSITPMHSDLTDYIKLKELRQSLS--------
27 UniRef50_D0MKC6 Stationary-phase survival p... 306 5e-82 1 43.2% 3:243 12:260 --ILVCNDDGINAPGIAALAAAMDALGEVYVVAPATEQSAVGHAITVRDPVRAYPwgEVPAYAVSGTPADCVKLAVNQLLPRRPDLVVSGINRGPNTAVNVIYSGTVSAATEAAILGIDAIAFSLCNwrDYSAAAHYARRIARTVLAHGLPPGILLNVNIPDLPLEKIKGIAITRQARSRWEESFAERRDPYNQPYYWLTGRFVNLDDGDDTDLEAVEQGYVSITPLQHDLTAHAYRAMLNQW----------
28 UniRef50_C6XTC8 Stationary-phase survival p... 305 9e-82 1 36.4% 2:243 15:261 -NILVVNDDGITAPGIKNLIDVMTELGNVVVVAPDGPQSGMGHAITIGKPLRFDAVdgVEMYKCSGTPVDCVKLAVNKIfgKKPDLCVSGINHGLNNSINVIYSGTMSAAVEGAIENIPSIGFSLDDFsdFSHCKKYIKVIAEQVLAHGLPAATLLNVNFPK--GDGLKGIKICRQANAKWAEEFDERKDPYERPYYWLTGVFQNYDKGEDTDVWALEHGFVSVVPVQFDLTAHHAIPVLNTW----------
29 UniRef50_C4GGR5 Putative uncharacterized pr... 303 3e-81 1 45.7% 1:247 1:249 MNILISNDDGYLSQGIATLARIAGEFANVRVVAPERDRSGVSNSLTLDRPLKIRSAEN-GFYYVSGTPTDCIHLGLHALADFQPDLVLSGINHGSNLGDDTLYSGTVAAATEAYLMGIPAVAFSLTSHEFHKYAakAVWNIVSRLVQNPPSAPILWNVNIPAVAPDQLRGHKIARLGRRHHTQSIVHATNPRGEDIYWIGAVGAVADNEQDTDFATCESGYVSITPLQIDLTAYSQMHALDEYWQGL------
30 UniRef50_C6HZU9 Survival protein SurE n=1 T... 303 4e-81 1 40.7% 3:243 8:254 --ILLSNDDGIDSKGIAVLEEAVEGLGEIYVVAPENERSAASHALTLHKPLRISERSPRH-FAVSGTPTDCVNLALFTILPRRPALLLSGINHGANMADDVTYSGTVSAAFEGSILGVPSMAFSlgEPLAFETARHFVRILAKRMLADSPPATIPFSVNIPSRPVDRVPGIRLTRLGKRIftGNIITKSDPRGRPYYWIGLSPTDYEPDPESDLHAVDHGYVSVTPLHLDLTHYPSLDRYRSW----------
31 UniRef50_A6CG83 Survival protein SurE n=1 T... 302 7e-81 1 40.2% 1:239 1:249 MQILLTNDDGIHAPGIRSLQKALTQLGDVEVVAPLSEQSGVGLSITYLHPLMIheSGKHWGWAVAGSPADCVKLGILEFCPQRPDLIISGINSGSNVGINVLYSGTVAGAIEGAFAGIPSIAISadTKPDYDRCAAQSIPIIRKLLQDPYPADRLWNLNFPEIRPDWPRGVKWTSLGVKRHFDVMEKRMDPRGRPYFWSGLDPIQNHqePGTDIHELSEGFVTVTPLKFDLTDHDHLQS--------------
32 UniRef50_C5RZW8 Stationary phase survival p... 302 8e-81 1 51.2% 1:244 1:258 MNILISNDDGINALGIKTLAATLREAGhvTVIAPDRNRSAASSCLTLTEPLRVHQFDEFNYTVIAGTPADCVHLALNGLFPNDFDLVISGINHGANLGDDIVYSGTVAAALEGRHLPLPCLAVSLvgNNHFETAAKVVLSLLPKLHKDLINPREILNINVPDLPYEQLKGVMITRQGKRSQAAEIVKSQDPRNGVIYWLGANGVAIDESEGTDFYAINHDYVSITPIQADMTAHRSLTDLQEII---------
33 UniRef50_A9B1D4 5'-nucleotidase surE n=4 Ta... 302 8e-81 1 43.4% 1:244 1:251 MNILLSNDDGVHSPGLLALKCQLEQLGCVTVVAPERNWSAGSHSRTLFAPLRVNEvdGSPALACDGSPADCVGLALLGVMDHRPDLVVSGINLGANLGHDVLYSGTVAAAMEGLVVGIRSIAVSLVDgsDFSVAADWARRIAATAMELQLPSDILLNVNVPQGSAEIVNDAKVTRLGHRIYRDELIKRLDPRGRPYYWVGGAAPDGKPDDGTDFGAVANNHVSITPLHFDMTNLDWVQRLSTAI---------
34 UniRef50_Q2S1H7 5'-nucleotidase surE n=1 Ta... 302 1e-80 1 39.3% 2:243 11:260 -RILLCNDDGIHAPGIQSLASALDGLGELFVVAPTTEQSAVGHAITVRDPVRAHREepIPAWGVTGTPADSVKLACHELLDAPPDLVVSGINQGPNTAVNVLYSGTVSAATEASILGLDSLAISLcsKPQFEVAGQWARRIVEWALDRGLPQGVLLNVNVPALSAEQIEGVALTRQARSRWEEGFERRTDPADRPYYWLAGTFVNLDDGPETDLSAIERGYVSVTPIQHDMTAHDAFEAFGTW----------
35 UniRef50_C1A8T7 5'-nucleotidase surE n=1 Ta... 302 1e-80 1 45.5% 1:246 1:251 MRILLSNDDGILAKGLGVLERAAESLGELHVVAPDREQSATSHSLTLHHPLRPVRLGERR-WQVDGTPTDCVMLACEALLEARPDFVLSGINHGPNMGEDVLYSGTVAAAMEGLALGIPAIALSFAGnaLLDTQVGAIRSLLHHLTGLpfPADTLLNVNLPAVPGDEIRGIRLTRLGRRVFSDSIARMKDPWGRDILWIGGGSVEWSGAPDSDFRAVHDGYISVTPLHLDLTHRDVLNTSTEWWQE-------
36 UniRef50_B0RTZ9 5'-nucleotidase surE n=20 T... 301 1e-80 1 56.3% 1:247 1:251 MRVLVSNDDGVDAPGIQILAEALRRAGhvMVVAPDRDRSGASNSLTLDVPIRTRRIDAQTC-AVAGTPTDCVHLALTGMLDYDPDIVVSGINNSANLGDDVIYSGTVSAAMEGRFLGLPAVAVSLVTqhHFETAARAAVEIVARLKADPLPADTILNVNVPDLAWADVLGFEVTRLGNRHRSEPCVPQSDPRGRTVYWIGPAGPEQDAGAGTDFHAVRTGHISITPIHVDLTRYQALDTVAGWVGGL------
37 UniRef50_Q2LUH7 5'-nucleotidase surE n=2 Ta... 301 2e-80 1 39.2% 1:245 1:251 MRYLLTNDDGIYARGLSALYSELSKDADCLIVAPEVERSAVGHAITLNRPlrTKKDGNFLGYAVSGTPADCVKIGIKELSEKPVDLVVSGINIGANVGINVIYSGTVSAATEGAILGVPSMAISLGtnADYTFAAHFARTMARFIMKYFEKKSVALNINVPALPVQDIKGYAVTRQGKARLIESFDRRVDPRERLYYWLAGETQLSeeEPDSDGSALSRGMISITPIYHDMTRYDALDGLKALLS--------
38 UniRef50_A7HXK5 5'-nucleotidase surE n=95 T... 301 2e-80 1 40.2% 1:249 9:265 LRILVTNDDGIHAPGLKVLEKIAHKLsdVWVVAPEDEQSGSAHSLSLANPLRVRKLTARK-YAVRGTPSDCVLMAVRHIldEQPDLVVSGINRGQNIADDVTYSGTIAAAMEGTQLGIPSIALSQAfnVKWSTAEHFAPDILKKLIAAGWPEEVLININFPDVVPGSVTGIEVTRQGKRDQsvRVEERIDARNNPYYWLGFERILSNPPQGTDLRAIYESRISITPLHMDLTHQKTAKALNDALGTLAQ----
39 UniRef50_C8W6F2 Stationary-phase survival p... 300 3e-80 1 38.3% 1:248 1:257 MRLLLSNDDGINAKGIKTLAERLSKTAEVFVVAPDRERSSTGHGITVYRPLMVTecKDVVAWSISGTPADCVKLGIDELLPARPDLIISGINNGSNLSTDVLYSGTVSAAIEGVINGIPAIAVSLANneDFSCAVGFTENMVSNFISTGMYPGVMLNINVPA---GKPSGVKVTQLGLRRYVNCFEKRTNPRGKVYYWLAGEPIDVETglDIDSKAVKDNFISITPIHFNLTHFDEIENLNKWVKELR-----
40 UniRef50_D0XW22 Stationary-phase survival p... 299 6e-80 1 38.2% 1:246 1:255 MRILLTNDDGIHAPGLKALETIARALSdvWICAPEYEQSGASRALTLSDPIRVRKLDDRR-FAVEGTPTDCVMMAVQQLIdpAPDLVLSGVNRGQNLAEDVTLSGTVAGAIEGMAHGIRSIALSQTMnaHWETAEHFGPGIVQRLLEVGWPADVVMNVNFPALPPEKVAAVEVTRQGFRdlLRNMEKRTDLRGRDYYWMGFSAKASEPAEGTDLRAVYEGKISVTPLHIDLTHHESVHKLKSLLGG-------
41 UniRef50_B2VA83 5'-nucleotidase surE n=5 Ta... 298 1e-79 1 40.1% 1:242 1:249 MkvFLTNDDGYQSKGLQAIRNRleENFRVITVAPDRNMSGTSHSLTFTRPLKIEKIEEDFYYIVDGTPADCVHLGLNVIlnQKPDLLISGINTGPNIGNDVFYSGTVGAAREGTLFCIPSVAFSVGsnPNFEDVSKVAVKIVKALLIKNLPKGTFLNVNIPTIPAEKIKGFLLTKQGRGAYKEEIVKYLSPSKEEYYWIGGEEALLEesPGTDYTAVKDGYVSITPIRLDLTDHKAIDILDK-----------
42 UniRef50_Q6FCV6 5'-nucleotidase surE n=1 Ta... 297 2e-79 1 45.3% 1:245 1:255 MNILIANDDGVFAPGIQALAHALKPLGRVVIVAPESERSGYSSALTLDRPLRPIQISE-DVWAVNGTPADCVYLSMNGLFDFEFDLVVSGINSGANLGDDVLYSGTVGAAFEGRLMKQPAIAVSLAGshDYAVAAKWVHDFIQKGLPN-LPPRHILNINIPDVAA--LKGERVTYQGLRAQSKPITSHVDPRGRQVYWIGLAGEAVTDPKKtdFFAVANGYVSITPIQMDATNYDILEDLQTYIG--------
43 UniRef50_Q3ATV8 5'-nucleotidase surE n=11 T... 297 3e-79 1 35.1% 2:243 22:268 -HILICNDDGIEADGIHALATAMKKVGRVTVVAPAEPHSAMSHAMTLGRPLRIKEYQKNggYTVSGTPVDCIKVALSHILTEKPDILVSGINYGSNTATNTLYSGTVAAALEGAIQGITSLAFSLATYedFTYATKFARKLTKKVLAEGLPADTILSVNIPNVPESQIAGVIIAEQGSSRWEEQAIERHDMFGNPYYWLSGSLQLMDHSMKKDEFAVRHNYVAVTPISCDLTNYAALAGLEKW----------
44 UniRef50_D0SVB2 5'/3'-nucleotidase SurE n=1... 296 4e-79 1 43.9% 1:246 1:256 MNILVSNDDGVFAPGIQALAQALKPLGRVVIVAPESERSGFSSALTLDRPLRPIQIS-PDVWAVNGTPADCVYLAMNGLFDFEFDLVVSGINSGANLGDDILYSGTVGAAFEGRLTKHPAIAVSLsqPQDYQLAAEWVHDFIARGLPV-LPERHIFNINIPDVT--ELQGEKVTYQSRRRQSKPVTSHIDPRGRQVFWIGLSGEAVADPkdSDFSAVANGYVSITPIQMDATNYESLRNLQTQLAE-------
45 UniRef50_B1XPE2 5'-nucleotidase surE n=32 T... 295 1e-78 1 40.3% 1:243 7:275 LNLLISNDDGISALGIRTLANTLAEAGhvTVVCPDRERSATGHGLTLHRPIRTEIVEgvTAWSCSGTPSDCVKFALSAVLKERPDFVLSGINHGSNLGTDVLYSGTVSAAMEGLLEGIHSIALSLADYtnFQPAADFAVKLLCQLMEKRpdAPVLLNINVPNLEKEKLAGVKITRQGLRRYIEQFQKRQDPRGKTYYWLSGEVIEELPQPdtDVQAIAAGYITITPLQYIMNDLHRIQTleDW----------
46 UniRef50_Q67NP4 5'-nucleotidase surE n=1 Ta... 293 3e-78 1 42.7% 3:243 4:252 --VLLTNDDGIFAPGINALRARMEQIpeVWAVAPDRERSASGHAITTYRPLFPVRVEIPGAVavTGTPADSAKLAIEAILPRRPDLVISGINRGANLGTDIFYSGTVAAALEGPILGIPALAVSLDssSDYSAAADFAAQLALKVLEEGLPEGTLLNVNVPALPREAIKGVRVTKVGRRIYRDQWVRRMHPRGQEYYWLAGELAEIHNDRESDVSAVEAGYISVTPVHLDLTRYDQMDRLRQW----------
47 UniRef50_B8DN39 5'-nucleotidase surE n=6 Ta... 293 5e-78 1 39.3% 1:252 1:256 MIVALTNDDGIQAPGLRAMYKALLDAGhvHVVAPVTEQSAVGHAVTISLPLRVKEFHENGFRgvYGTPTDCVKLGLSCLLDKKPDVVVSGINAGANVGPDILYSGTVSAATEAAHMGYPALAVSYDspADLSGQAAHAAGLLATLDWQALPARCVVNLNYPAVPMPEVKGVRACPQTRAVWKDWYDHRTDPRGGSYWWLNGVIPPETVAPGTDRALLTEGWITLTPLRFDFTDHEAMDVLAR-VQGDGVGGQ-
48 UniRef50_A8ZXL1 5'-nucleotidase surE n=1 Ta... 292 8e-78 1 39.1% 1:243 1:248 MNIVLTNDDGIDAEGLLALYRVFSRDHRVVVVAPEAERSAVGHGISLHQPLRVNQraGGEWYAVSGTPADCVKLGILALLDPRPDLVISGINAGLNHGAYMHYSGTVAAAREACVYGVPSIAVSMDGYpyFDEGASLTQTLVERLAEMEMPANTFLNVNMPDLPRERITGICFCSQDVLPPGDRVDMRNDPRGLAYYWYAYDNTHGDGTGDTDRAMLRNGTVSITPVTCDGTHYGVLERLKQF----------
49 UniRef50_A3M7F7 5'-nucleotidase surE n=15 T... 292 9e-78 1 44.9% 1:245 1:255 MNILIANDDGVFAPGIQALADALKPLGRVVVVAPESERSGFSSALTLDRPLRPIQIAE-DVWAVNGTPADCVYLSMNGLFDFEFDLVVSGINSGANLGDDVLYSGTVGAAFEGRLMKQPAIAVSLAGpdDYAQAAKWVHDFIAKGLPA-LPPRHIFNINIPDVP--QLKGTQITYQGRRAQSKPITSHVDPRGRQVYWIGLAGEAVTDPqqSDFFAVANSFVSVTPIQMDATNYAVLEDLQASLG--------
50 UniRef50_A1KUT0 5'-nucleotidase surE n=23 T... 292 1e-77 1 42.9% 1:245 1:246 MNVLISNDDGYLSEGIAVLARVTAEFANVRVVAPERDRSGVSNSLTLERPLQLKQAQN-GFYYVNGTPTDCIHIGQSVFSDFQADFVFSGINRGANMGDDTLYSGTVAAATEAYLMGIPAVAFSLnsGRYWATAEKALWTLLAHFFKNPPQSPILWNINIPAVEPEDVRGIKIARLGRRHHGQNVIPARNPRGEQIYWIGPVGRVSDKEEGTDFGECGAGFITVTPLQIDLTAYPDMAETAAFWH--------
51 UniRef50_A1TM17 Exopolyphosphatase / 3'-nuc... 290 4e-77 1 46.2% 1:249 1:254 MKILLSNDDGYQAPGIVALHAALREIpdVDVVAPEHNNSAKSNALTLHSPLYVHQAAN-GFRYVNGTPADCVHIALTGLLGYRPDLVVSGINNGANMGDDTIYSGTVGAAMEGYLFGVPAIAFSQvgWGEIEAAARKAREMVEQMHAQHleVPWLLNVNIPNLPFDQLRPVQVCRLGRRHAAERVIEQESPRGERMYWIGGAGPAKDDSEGTDFHATALGHVALTPLKVDLTDHEGLAYWSDTAGRLAQ----
52 UniRef50_D1R4R4 Putative uncharacterized pr... 289 5e-77 1 36.4% 3:249 9:262 --ILITNDDGIHAPGIKHLWQAISSFADVTVVAPATEQSAVSLSITIRNPLHIEKVtnVDVWSVSGTPADCVKLGLNVVLESPPDLILSGINRGTNAGRNVLYSGTVGGVIEGIMHNIPGIAFSCYDFHdyATAEKYIPLIVRHILQHPLPNGTFLNVNFPPKHLNEIKGIKLTRQGKEYWVENPDKREHPngNSYYWLGAKLAKFEEEADSDIPLLQQGYLTAVPVHveLTDHHHLTAHRDHFEQLSL----
53 UniRef50_Q2NDM8 5'-nucleotidase surE n=2 Ta... 289 5e-77 1 40.4% 1:245 1:252 MRILLTNDDGIHAPGFEVLEDIARELSdiWVCAPAEEQSGAGHSLTLHHPVRLRQLGERR-YSVTGTPTDSVMLALRTVLEDkpDLILSGVNRGANLGDDITYSGTASAAMEGALGGIKSIALSQVYKRdfDAARTYGADVIRKLIDAPFGDRTLININFPPLPADKVRGIRAVRQGFHDyrGSVVKGRDPRGLEYYWFGLYAIEHTLDHGTDLEAIDEGFVSVTPLQLDLTQHSLLSVIGERFE--------
54 UniRef50_B5YE72 5'/3'-nucleotidase SurE n=2... 289 6e-77 1 35.0% 2:241 5:247 -KILITNDDGINSPALKIMGKELSKLGEVYIIVPERERSGGSHAITLHKPLRVNEVKWpkVWSTNGNPADCVLLGLYAILSQKPDLVISGINKGYNLGNDIIYSGTVSGAREASLNGIPAVSISVSqeEDFKKATELLIRLFGKFLKI-IPEGTFLNINVP--PNAKVDEICFTYQGKFHYRNIVERRLDPRNKEYFWLHGYIEEI-GEEGSDIWAVKNGKISITPLQSDMTNYSLLNLLK------------
55 UniRef50_A5EY39 5'-nucleotidase surE n=1 Ta... 289 7e-77 1 44.0% 1:248 1:250 MFLLLSNDDGYASAGMRALVEVMEGAVelIVMAPESNCSGVSHALTLTRPLTVQTHGNA-IYSVNGTPADCVRVAVGGYFDEVPDMVISGINCGANLGDDVLYSGTVAAAFEGRYLKFPALAISNVAHrhLADTAQIVLDLFSFFKKNPLTGATLLNINIPDLPRAEIRGIRVTRLGQCRQERPLEKMINPRQEECYWIGANKGGFLADEGSDFAAIEQGFVSITPLQFDVTHDDQLEAVKHWLEPMR-----
56 UniRef50_Q2RTH6 5'-nucleotidase surE n=6 Ta... 288 9e-77 1 40.7% 2:244 12:261 -RILLSNDDGFEAEGLAVLERVARTLSdvWIVAPETEQSGAGHALTIHDPLRFRARGEKR-FSVRGTPTDCVLVAVNHLMDRPPDLVVSGINRGGNLGEDVHYSGTVAAAMEGTLLGLRAIALSQVFETnfQVAATHASDVIRRVCGRPWNRQVLINVNFPDCPLDAVTGIELKRQGRRKMGDDIEERRDPRDRPYLWIGAQRKEDRKTAGTDMEAISRGAITVTPLCVDMTDLPTIEALTGAF---------
57 UniRef50_Q72A55 5'-nucleotidase surE n=5 Ta... 287 2e-76 1 37.4% 1:243 1:248 MRIALTNDDGIQAPGLRAIYKALIEAGhvDVVAPVTEQSAVGHAVTIAMPLRVKVFHENGFRgvYGTPTDCMKLGLSSLLEHKPELVVSGINAGANVGPDILYSGTVSAATEAAHMGYRAVALSYDspEDISAHARHAAALLPHIEWAGLPERCVVNINYPAVPVESIKGVRVCPQTRAVWHDWYEHRTDPRGGSYWWLNGVIPPETVAPGTDRALLTEGYITVTPLRFDFTDSETLTRLASL----------
58 UniRef50_Q5HWH7 5'-nucleotidase surE n=18 T... 287 3e-76 1 35.5% 1:245 1:254 MkiLITNDDGYESEGLKKLIKMLTKeaKITIVAPASEKSACSHSITLTKPLRFVKVGKRFYKLDDGTPADCVYLALHALYKKrpDLVISGINKGANVGEDITYSGTCAGAMEAVLQGIPAIALSQFYKkdYKNALQITKKIIQNIFDKGFpkKEFLNINFP--AKSKIKGIKICKAGKRVYNFEAHSNVNPRGVEYYWLAAANLDFEDEKNSDIALLKKGYATITPIMLDLTAYERMKKVKKWLK--------
59 UniRef50_D1AMG3 Stationary-phase survival p... 287 3e-76 1 36.7% 1:245 1:254 MKILLSNDDGIFAKGIETLAMVLIERGhvYVVAPDEDASGTGHGLTINKPLRYRKygNFFGYMVNGKPADCVKLARWEIYRddFDFMISGINRGANLGVDLFYSGTFGAASEAALLGVRSIALSLSEpkNYLTAAVFAADFIEKIKDFQFPRYKLLNINVPNVKTEELKGYKFTIQGDRNYKENFDKRFDPNGHEYFWITGNAVEYSSNYHSDYYVLKDNYVSITPVALDLTDEKFGLQIEKELN--------
60 UniRef50_B9MFW6 5'-nucleotidase surE n=107 ... 286 4e-76 1 47.7% 1:237 1:240 MKILISNDDGYQAPGIVALHDALKTIADVEVVAPEHNNSAKSNALTLHSPLYVQTAHN-GFRYVNGTPADCVHIALTGLLGYRPDLVVSGINNGANMGDDTIYSGTVGAAMEGYLFGIPSIAFSQvgWGEIESAARKAREIVQQMDRQNleAPWLLNVNIPNMPYDALRPLRMCRLGRRHAAERVIEQQSPRGELMYWIGGAGAAKDAAEGTDFHATAHGHVSVTPLKVDLTDYDGL----------------
61 UniRef50_Q7UKT6 5'-nucleotidase surE n=3 Ta... 286 6e-76 1 35.8% 1:243 1:249 MRILLTNDDGVHAPGLAALRQQLRHLGEVITVAPATEQSGVGHSITYLTPlsIHRDGVHWAWAVEGSPADCVKLSLAELfdEPIDLVVSGINNGLNAGINVLYSGTVAAAIEGAFFGVTSVAVSLENSDdfDAAAVIARNVIGEIVRHEESRGGLFNLNVPTAATESASEVKVVPMGLAQYGRRYEKRQDPGGRDYYWALWTQPDKPPAEMTDVTQLREGCVTLTPLHFNLTRDDLLSEMKDW----------
62 UniRef50_B0VI54 Broad specificity 5'(3')-nu... 286 6e-76 1 39.9% 1:243 1:245 MKILLVNDDGILAPGIRTLAEELKNAGhiTIVAPDSERSAASHSLSIRKELIVKKIAENE-YAVSGTPVDCSVIALQKILTEPVDLIISGINAGQNMGEDVLYSGTVGAAMEAALLGNRAIAVSINSYKnfEVAAYWMRKLLDLGIDKQAEAFGVLNINIPNLPLEEIKGIRLTRTGHRKYYNFVKIIKENEDGFVYEVGGDIPVWDNETGTDAEAVNNGYISLTPLGFELTRSETFPRILNW----------
63 UniRef50_Q1ATN8 5'-nucleotidase surE n=1 Ta... 285 9e-76 1 42.8% 1:243 1:257 MRIVLTNDDGIEAPGLLAARRALEEVGEVITVAPDRNRSGVGRSITFGAELYVEErdGGVGYACSGTPVDCVRlaLGMVEGFRPDIVVSGINHGENLGDDITYSGTVAGALEAIVIGVPGIAVSLSTGrhFEPVARFTARLAG-LALRDLPPGRILNVNAPNLPEEELEGARVTRLGRRFYQDELIEVRDKNGRVGYNIYNNPPGHHDEEGTDFAALQSRRISVTPVHLDLTDTAGLKELESW----------
64 UniRef50_C5RLV0 Stationary-phase survival p... 284 2e-75 1 37.4% 1:246 1:248 MRLLIVNDDGINARGIQILAKELHKHHEVIVAAPNVQRSASSHSITLNSTLTIKEEIVPEvySINGTPADCTRLAVEKLMNFEVDLVISGINDGYNLGTDVLYSGTVSAAIEAAVVGVPAIAISCDGTEefRRGAEYALKVIEKLKDNKLSENIVLNVNIPK--TEAVKGIKICSMGERIYKDVFFETLSEEGSRTYDIKGTPCDSD-DETTDVGIITKGYVTVTPLHYDLTNYNILKETEKVFSE-------
65 UniRef50_B0T1Q2 5'-nucleotidase surE n=8 Ta... 284 2e-75 1 36.4% 1:247 1:256 MRILLTNDDGIHAPGLGSLERIARMLSdiWIVAPEYEQSGAGRALTLSDPIRVRRIDPRR-FAVEGTPTDCVAMAMQQLIepAPDLVLSGVNRGQNLAEDVTLSGTVAGAIEGMAFGIRSIALSQAMtaHWETAEHFGPGIVQRLLEVGWPKDVIINVNFPAVAPEMVTEVEVTRQGFRdhMRSMEKRTDLRGRDYYWTGFVVKPSNPAEGTDLKAVYQGRISVTPLHIDLTHNQTVAAMKGALGGT------
66 UniRef50_B2UU78 5'-nucleotidase surE n=20 T... 283 3e-75 1 36.2% 2:247 3:265 -KILLTNDDGYHAKGIKALEQALEKMAEIYVVAPKHEKSACSQCITITAPLRAEKieGRHYKIDDGTPSDCVYLAINELFKHvfDLVISGINLGSNMGEDTIYSGTVAGAIEGTIQGVPSIAISqnTPLSFDLAQKIIQDLVQNIFTNGYpgRKLLNVNVPNCSLQEYKGECITPKGYRLYKKEVHKRTDPKNESYFWLGLHPLeeNEDRLSDFDAIASNHVSITPLNLDLTSYDDLKNLESWHKGM------
67 UniRef50_B6BWV8 5'/3'-nucleotidase SurE n=1... 283 4e-75 1 45.9% 1:244 1:243 MKFLLSNDDGYLAPGINELAHILSSIGEVVIVAPEENKSASSSSLTLKNPLTITEHKKN-IYYINGTPTDCVHIALSGFLKFKPDMVISGINDGPNMGDDTIYSGTVAAAMEGYLLDIPSLAISmyDPKYYATAGQVVLDLVPKIKD--LQQSMLLNINVPDLPYDQLKGLEITRLGKRHKAEPIIHHPNQNNKLMYWVGAAGEPNDGGPGTDFFAIKNEKVSISPIISDLTNFNKLDLLKENL---------
68 UniRef50_A5CVV1 5'-nucleotidase surE n=5 Ta... 283 4e-75 1 46.6% 1:247 1:246 MKILVSNDDGYQAQGIIELAQSLAQEHEVIVVAPSENKSAASSSLTLDKPLRPIQISNN-VYCIDATPSDCVHLALCGFLNEEIDLVVTGINFGANLGDDVIYSGTVAGAIEGRFLGLPSLSISLASWrhFKTAGIVIRQLINQISHAHLSYGTVLNINVPDVIFSDIKGFQTTRLGKRHMSE--QSVIDKNDSSLYWIGENGKEADNGVGTDFHAITNHYVSITPLQTDLTKYNEINTVSTWLNQI------
69 UniRef50_D1B9N2 Stationary-phase survival p... 281 2e-74 1 45.5% 1:242 1:252 MKVLMSNDDGILAPGIQIMAKVLADRgpCAVVAPDRERSSIGHAITLNRPLRVWHLEPgpAYACDGTPSDCVVIGVEELAKDVT-MVISGINRGPNLGDDLTYSGTVSAAMEGLILGYDAIAVSLACkaHYSTAAAVVVAFLDWFKQNHRQKGVLYNINVPNVPIRSLKGILPTKKGTRLYRDKVTKFRDPQGRECYWMGGVPEDR-LEEGTDVWAVSNGYASVTPIHMDMTHYDTLKEMSS-----------
70 UniRef50_C9MMA9 5'/3'-nucleotidase SurE n=5... 278 1e-73 1 33.2% 3:243 8:254 --ILISNDDGYHSNGIRTLVSFLTDFADVVVCAPESGRSGFSCAFSVTDYLLlhNIPNCEVWSCTGTPVDCVKLALDQLLKekPDLILSGINHGDNSSVNNHYSGTMGVAYEGCMKYIPSIAFsyNTEADLSYLRDYVRKIVKKVLTDGLPKGVCLNVNFPKV--EKFAGLKVCRMGFGSWTREVERCKHPRGFDYYwiGHYQNDEPDATDTDQWALNHGYVSVTPTRIDVTDYDMIEKMNTW----------
71 UniRef50_Q6MCW1 5'-nucleotidase surE n=1 Ta... 277 3e-73 1 36.2% 3:237 7:249 --ILVTNDDGVHAKGIRHLWQSIQDLADLIIVAPQQEQSAVSLSITVRRPLHIEKVdqADVWSVNGTPADCVKLALNVVLPKRPQLIVSGINRGTNAGRNIFYSGTVAAIMEGVMQGIPGIAFSYGdnPSYHLIESFIPGIVNYALQNAMQEGTFLNVNFPKTEHGPIKGIRLTTQGKEYWAENPEKRQHpeQNSYYWLGSKLAEYDEREDSDIFLLRKGFATVVPLHidLTNHSHL----------------
72 UniRef50_B0ACR2 Putative uncharacterized pr... 277 3e-73 1 39.7% 1:237 1:243 MNILISNDDGINAEGIKILAEEISKIANTYVVAPDSPRSASGHAITLHKPILINdaENVEAYSTSGTPADCVKVGIESILKdeIDLVLSGINNGPNLGTDVIYSGTVAAAIEGLVEGKPSIALSCDSSkeYREAAKYTAKLIQKLEGndKLNGNILNVNFP---TGEKKGVRITKLGRRVYNNVMDDRQSIRGQRYVWMGGDLEDIKQDKDSDIFAVENGYISITPVHINMTETNRI----------------
73 UniRef50_C5A6M8 5'-nucleotidase surE n=4 Ta... 277 3e-73 1 35.2% 1:244 1:255 MRILLTNDDGIYSNGLRAAVKALSELGEVYVVAPLFQRSASGRAMTLHRPIRAKRVDVPgaYGIDGTPTDCVIFAIARF--GSFDLAVSGINLGENLSTEITVSGTASAAIEASTHGIPSIAVSlgEGVDFSVSAHFLRRIAGAVLERGLPEGvmLNVNVPSDATEDTK-MAITRLARKRYSPTVEERIDPKGNPYYWIVG-RLVQDFEPGTDAYALkeRKVSVTPINIDMTARVDFEKLKNVL---------
74 UniRef50_C6XIZ8 Stationary-phase survival p... 277 4e-73 1 32.8% 1:247 1:255 MRILVTNDDGIDAPGLVVMEEIARSISdvWMVAPLVEQSGQGRAITVSEAVRIDQRGEKRFR-IEGTPTDCVVLGIEHIldKKPDLILSGVNNGQNVGEDTTQSGTIGAVVQGMLMGVPGIAFSqgKSMAWDTGRHFGPKVVKRLLETGWPKSVVMNVNFPDCEIEDVKGTEITSQGLRDFSinSEKRTDPRGRDYYWLSHGGPKSDPPGGTDLRCIYEDKISISPLHVDLTHYAYRDTLIESFGEL------
75 UniRef50_Q899M5 5'-nucleotidase surE n=2 Ta... 276 5e-73 1 34.4% 1:244 1:249 MRLLLTNDDGVNSKGIYTLAKELQKEHEIIIAAPSIEMSAKSHSITIAKPLFIKEVenATTYSISGTPADCVKVAMDKILDKPVDMVISGINYGTNLGIDILYSGTVSAAIEAAIHNIPSIAMSanGDINFDTAASIARELVKISQENSMKGNLVLNVNVPCLDKDSLKGLKVCQMGGRTFTSYFEKIE--KNKEVSYMLKGELTNNHKPTTDIHFLRKGYTTITPLHYDLTNFKIMNDVSNWF---------
76 UniRef50_C4V2A9 Acid phosphatase SurE n=1 T... 275 7e-73 1 35.2% 1:244 3:253 LNILISNDDGIAAEGIHVLARRLSGAHHVTVAAPMHQQSGTSHALTIGRAIEVREDENFDawAIDGTPTDCAKLYLDAIAEERPDVVLSGINHGSNLGTDVIYSGTVGAAFEGYFHGISSFalLDGSSLSFADAAEYFVPFMEQVLAA-ADQPFLLNINFPKELAGDEPRFVFCRQGGRDYVNAFERIEMEEGRVHYKVAGEVSDTDKGIGTDIYAVEHGLIAVTPLGVDMTDYPLLRQLGDAL---------
77 UniRef50_A5GUT4 5'-nucleotidase surE n=26 T... 275 1e-72 1 41.2% 1:240 5:259 LKILISNDDGVFAEGIKALAHEAARRGhvTVVCPDQERSATGHGLTLQSPIRAEQADgiRAWACTGTPSDCVKLALGKLLEAPPDLVLSGINHGPNLGSDVIYSGTVAAAMEGTLEGLPALAVSSadWRQFDGAAVQAMDVAESALAGGWPEGLLLNLNVPAVPPDRIGPVRWCRPGVRRYVDQFDERFDPRGRSYYWLAGEVVNDFEAAgtDVAQVQGGGVALTPLQPELFWRGALPPL-------------
78 UniRef50_D0LY90 Stationary-phase survival p... 275 1e-72 1 40.1% 1:237 6:244 MkvLLSNDDGIGSPYLQALADALDATGEvlVVAPERQRSAASHAITLHKPLRLHKHGERR-FSLSGTPVDCVYVGLIKLAERAPALVLSGINRGYNLGLDVFYSGTVAAAVEGGLRGVPAIALSLAPEedLQSALRFSVALALQVVANPLPPLTVLNVNFPVQPDERWA---WTGLGKRAYEDDVHERFDPRGQPYYWIGGGSAELGDDRCTDCAAIGAGITTVTPLRLNLSGHGLL----------------
79 UniRef50_C9KKZ7 5'/3'-nucleotidase SurE n=3... 275 1e-72 1 36.0% 1:242 1:258 MRILISNDDGIQAKGLEALVKAFCARKhvIVSAPARQQSGMAHALNVGRPLELVRGegIEAWAVDGTPTDSVKLYLEALAEEKPDVVVSGINHGANLATDILYSGTVGAAMEGMLHDIASFAVSmdSTISYEEAAEEFATILERVmaSDEPRPVFWNVNFptLGDDGRPQVVFGRQGKRDYHNAFQKQERTDGRIFYTVAGEIFDTDKSEPTDIYAVEHGYIAVTPLMVDLTDYVAIEKLLD-----------
80 UniRef50_Q8D2P7 Exopolyphosphatase n=1 Tax=... 274 2e-72 1 50.2% 1:247 1:247 MNILLSNDDGIYSPGIQKLSKKLKKFLNVQVIAPSCDKSGSSSSLTINNPLKVHKFSNGDITVYSGTPIDCVYLGINFFMKPKPDFVVSGINLGANLGDDVFYSGTVGAAMEGRYLKYSSLAISLDGNKHLDVAVEIVYKFLKFLLNNPFRKKYILNINIPDSPLKYIKGFKITKCGRKNFKNTVIKSKDSENKNIFWIGPKTNCYNESIGTDFHAIKNNYISVTPLLSNLTNNKEINSISNWFENF------
81 UniRef50_Q30QB8 5'-nucleotidase surE n=15 T... 274 2e-72 1 33.6% 2:245 4:264 -KILVTNDDGYEAKGLRALVKALKELEDvmVVAPASEKSACGHSLTLVRPLRFVGVDDNFFKLDDGTPSDCVYLALSTIydSKPDLLISGINRGSNMGEDITYSGTAAGAMEGVLHDVPSIAISqdPQGDFTLAQKVIKELVIKIKNgpLPQREFLNVNIpdSTDNRDAKMVVTYAGYRFYANDSHIHRNPRGEEFYWLGLHPLDFLPREgsDYEAIEAGNISITPIQLDMSAYKSMNKLKEWIE--------
82 UniRef50_C7P7T8 Stationary-phase survival p... 273 3e-72 1 34.9% 1:232 1:248 MDILIVNDDGIYSSSLIALYKALKEkaNITIVAPTNQQSGIGRAISLFEPLRMTKveNIFGYAVSGTPTDCVILGIYQILKKVPDLVISGINIGENLGTEIMTSGTLGAAFEAAHHGAKSIASslDIPINFEIPAKITARIAEKYLKYDMP-CDVLNINIPENATLE-TPIEITRLARKMYTTHVEERVDPRGRSYYWIDGYPI-FEEKEDTDVYVLrkGHISITPLTLDTT---------------------
83 UniRef50_C3JBG6 5'/3'-nucleotidase SurE n=2... 273 4e-72 1 36.3% 2:246 6:255 -HILISNDDGIHAPGIAALSTMLRTIGDVTVVAPEGARSGASSQITSSLPLKleEEEGYRVYRCTGTPADCVKLALNVLFSkrPDLVVTGINHGRNDGICVVYSGTVGAALEGCIAGIPSLAVSVNDHGDDAeaVAYTNTLVRWMLSNKIPTHTMLSLNLPSTTP---LGFKVAPQAVGRFRDEFLESTNGSGGRVYWMVGSQVKTEDEPNTDWDLLEEGYATLTPIRIDMTDRNFLPQLHEAFRD-------
84 UniRef50_B4UE89 5'-nucleotidase surE n=16 T... 273 4e-72 1 43.2% 1:243 1:243 MRVLLSNDDGVHAAGLKALADAFHGD-EVWVVAPDREQSASSHAISLHRPLRLLEVA-PRWYAVDGTPTDAVYMGLNLVLRdrPDVVVSGVNHGPNLGNDVLYSGTVAAAMEGALLGVNAVAVSLAAPpdFGEAARFAAALARQVVARPPPAPVLLNVNVPPGP---VRGYRFARLGRRTYGNEVVEKTDPRGRKYYWIGGEGRVHNEdpGSDCnvLLERLAAVTPLHLDGTHDPMFQELRSW----------
85 UniRef50_B1H035 5'-nucleotidase n=1 Tax=unc... 273 5e-72 1 38.6% 1:241 1:241 MhiLISNDDGVKAPGLRPLMKELSKIGKVYVIVPKTQMSGTGHGITLAKYKKVEKIEKDFYVIKGGTPADCVKYGLYHFFKNKTDLVVSGINTCPNLGQDVIYSGTVGAAREGALRGVPSLAVSAAEvtEYEHSAIATREIAEKVLKrkFFKNICLNINIPQ----NYKGIKVAPLGLRIYDESVETVVDERGNFSYRLSGKYISGGKNKGTDIDTVDKGYISVTPLRIDQTDFTFIKKLN------------
86 UniRef50_A6L1M6 5'-nucleotidase surE n=33 T... 272 7e-72 1 32.8% 3:243 8:253 --ILLSNDDGVEAKGLNELIRGLRGMGEIIVMAPDGPRSGASGAITSEHPVkvREEEDLTVYKCTGTPVDCVKLALHTVVPRRPDVVIGGINHGDNSSVNVHYSGTMGVVIEGCLKGISSIGYSLCNhaDFSSSLPYIRRITEQVLEHGLPLGICLNVNFPDTAS--LKGVRICRQTNGAWINEWKRSLHPRGGEYFWLTGEFDNYEPeeDSDHWALGHGYVAVTPTQIDVTAYGMMNELKNW----------
87 UniRef50_Q3ZXG5 5'-nucleotidase surE n=5 Ta... 271 1e-71 1 39.0% 1:228 1:235 MRILVSNDDGIYSPGLWALVKRLKEVGEVIVVAPDREQSATGTQVTLRQPLRVQkiPGIEAYAVEGSPCDCVILGLAKLITEPVDLVVSGINHGLNLGDDVLISGTVGAALQGYLRNIPSIAIsmEEPENLDSAACITAEVARRIQNGDITKNSFLNINIPDLPLSQIEELRVTPLAHKTHIETVEEGHDGR-KRYFWLRRRQLSSADNKKTDIWAIENGYITISALH-------------------------
88 UniRef50_Q5NNV1 5'-nucleotidase surE n=5 Ta... 270 2e-71 1 36.9% 1:244 1:253 MRILITNDDGIAAQGIKILEEIAHKISdvTVVAPDKERSGMAHSLTLSLPSRLYKHDDRH-YSVSGTPSDSVVMGIKEIMKdpPDLVLSGINHGANLAEDVTYSGTVSAAMEGAIAGIRSIGLSQVYSPdfDTAVSWGEKVIRQLIDSTLPNRTFYNVNFPACENDDVKGIRVVAQGHRDYGrnVEKGVDPRGKDWYWLALGEAISKDNLNGDLDLSYQNYVTVTPLAPNLTDVASLQPLTDIL---------
89 UniRef50_B6YUP1 Acid phosphatase n=2 Tax=Th... 269 6e-71 1 32.7% 2:246 3:258 -RILITNDDGIYSKGIRAAVEAVKDLGEVYVVAPLFQRSASGRAMTLHKPLRAKLVNVPgaYGLDGMPVDCVIFALARF--THFDLAISGINLGENLSTEITVSGTASAAIETATHGIPSIAISlgEGIDFSVASHFLRRITRTVLEKGLPKGvmLNVNIPNDATPE-TGIKVTRLARRRYRPTIEERIDPRGYPYYWIVGRKCEK-FEPGTDAYTLkeRKVSVTPINIDMTAGVDLKEVERLLRS-------
90 UniRef50_B7B5A0 Putative uncharacterized pr... 267 2e-70 1 32.9% 3:245 40:287 --ILITNDDGVEAKGIKELTECLRDLGDIVVFAPDGPRSGMASAITSLVPIrvKKEKGLTVYSCTGTPVDCVKLAINEVLERKPDLLASGINHGGNHAICIQYSGTMGAAAEGCVFGIPSMGVSLLDHrdFTESCRLGRMLARRIIKEGLPHGTYLNLNVPNVP--NVKGMKVCRQADGRWTNEFKRSENAAGEPVFWLAGaeNAKPIHADNDTLALDSGYASLVPCKIDVTDYDFLAVLKNQLK--------
91 UniRef50_Q12U23 5'-nucleotidase surE n=3 Ta... 266 4e-70 1 32.5% 2:244 4:261 -RILLTNDDGVYAAGIRAAYRSVSDLGDVTVSAPAQQQSGVGRSISIFEPLRITriDGIEVHAIGGTPTDSVILGIFTIMKELPDLILSGFNIGENISTdiTTSGTIGAALEGASYGVPAIAASldFQHDFDVGIKFVNGVAKKVLKNGLPENvlLNINIPHFVEEDSE-VEITRLARKFFRTGVEERRDPRGRPYYWIAGD-LIHTAEKGTDVNAIEKGHISVTPISLDATSPINFSEIEHLM---------
92 UniRef50_A9AAP6 5'-nucleotidase surE n=12 T... 266 5e-70 1 34.0% 1:247 3:264 MEILLVNDDGIYSNGLLALKNVISEeaNVTVVAPTNQQSGIGRAISLFEPLRITkaDCSEGYAVSGTPTDCVVLGVHQVLKKVPDYVISGINIGENLGTELTTSGTLGAAFEGAHHGAKALACSleSPIDFMTTARIVRNVFKKFLDDEFP-CDVININVPDNATEN-TPVEITKLARKMYSMHVEERIDPRSRSYYWLDGYPI-MDEEDGTDVYAVRnrNVSVTPLTLDNTAKNLDEFREKYAKKF------
93 UniRef50_Q0W2Q3 5'-nucleotidase surE n=2 Ta... 266 6e-70 1 34.7% 2:246 4:264 -RILITNDDGVASPGLMAVYEAVRSLGEAVIVAPASQQSAVGRSMTLFEPLRIEklQGTMAYAVNGTPTDSVIMGMYVVmdRKPDLVISGINIGENLSAevTTSGTIGAAMEAANQGVPAIAVSmaMAQDYAVAQRLIGKLARQVLENGLPEGvlLNVNIPAGATPE-TPVVVTRLARRMYDTIVHHRMDPRGRSYYWVDGTIVA-DAPEGTDLHTVHQRrvSITPLRLDMTACEQTVEIERIIRD-------
94 UniRef50_D1PB54 5'/3'-nucleotidase SurE n=4... 265 9e-70 1 30.8% 3:249 46:292 --VLISNDDGYHANGIKTLVSFLKDWCDLLVVAPESARSGFACAFSATTPLRLKRRhdVEVWSCSGTPVDCVKLALDQFldRKPDLIIGGINHGDNSSVNNHYSGTMGVAKEGCMQHIPSIAFsyDENADLTPLRDGVLKVVKMVLEKGLPEYTCLNVNFPALPP--FKGFKGCRMTHGSWINEVDHRTHPHGYDYYWmgEYRNDEPEATDTDQWAVNHGYIAITPTKIDVTDY-------DWLKNFEL----
95 UniRef50_Q2FLE8 5'-nucleotidase surE n=8 Ta... 265 1e-69 1 35.4% 3:245 23:277 --ILLTNDDGVNSEGLWAAYDALFEWADVVVCAPATQQSAVGRSLSIFEPLRVNTvgDITAYAVGGKPTDSVILALFAL-GVKPDLVVSGINIGENLSYeiTTSGTVGAALEAANHGYPAVAFSldQKEKFDDARhvVRDVIRRILEKGFPSFtvMNVNIPSIITG---GYEITHLAEHLFITGVEKRLDPRGKPYYWING-PLVTDAPEGTDVHAIHKGNISITPITLDCTAYAGTDDLRRLFS--------
96 UniRef50_Q8TY72 5'-nucleotidase surE n=1 Ta... 263 5e-69 1 34.7% 1:248 1:256 MRILITNDDGIASPGLRAAVRACRSVGEVTVVAPATQQSGVGRSISLLEPVRVEevEGVDALAISGTPADAVLIGAFSIMDEPPDLVVSGINLGENVSADVTTSGTVGAALEAYGNGIPAIAISqaKNVDFTLAIRVLKALLEAIRGANWEG--VLNVNVPD--PDRWNgiKVVPLAFTMYRPRIEKRYDPRGRRYYWIDGE-IIQDPPEGTDLYELQRGSIVITPLTTDVT--GDLDAAENVIKELR-----
97 UniRef50_D1YY71 5'-nucleotidase SurE n=1 Ta... 263 6e-69 1 32.9% 2:244 4:261 -RILITNDDGISSSGLLAAYESVKGLGEVTIVAPATQQSAVGRSMTLFNPLRLTRLkgTTAYTVSGTPTDAVIIGMFVAMKKKPDLAISGFNIGENLSTeaTTSGTIGAALEAAGQGVPAIAVSmnFKRDYSAAINVVGKLAQCVLEGKLPAGvvLNVNVPAHAGPK-TPVVVTKLARKMYDTRVHRRKDPRGRSYYWIDGTIVE-DAAEGTDLHTikKGMISVTPLTMDMTSPSNTKGLEKML---------
98 UniRef50_C2MAB7 5'/3'-nucleotidase SurE n=1... 261 2e-68 1 38.3% 1:243 1:250 MKILLTNDDGVHAQGIRELAETLAQIATVTVVAPTEPRSGASSQITSRTPLRITLMEESelYSCSGTPVDCVKLALNTIFATtpDLVVSGINHGRNDGICAIYSGTAGAAIEAAIARIPAVAFSLADHsdFSEVCAFAKQFIPQVMEHGLPRTTMLNVNFPKAPA---KGIKWAPQGTGRFVNEYMRSETPHGTPVYWMQGDQVDPDHRTGTDHYWLVEGYATIAPLQIDMTDHPFLERakEW----------
99 UniRef50_UPI0001C30ED4 stationary-phase survival p... 261 2e-68 1 42.0% 1:243 1:258 MKVLLTNDDGIEAEGINALRRALVELpeLLVVAPDGNRSATARSITTRRPLWVEEVdgTIGYATDGTPVDCVRLTRLGLVefMPDIVVSGINHGLNIGDDVTYSGTVAAAFEALLLQLPGIAVSQQSTadFSAAAAFTARIVEELDSVPFETGTLLNVNVPGMHPD---GAEVTRLGKRFYRDVLedEAHPR-RRRFHIYGDAQDLVDDAGTDIAAVAAGRISVTPIHFDLTSHAGLEPLRGY----------
100 UniRef50_B2RH81 5'-nucleotidase surE n=2 Ta... 261 2e-68 1 36.9% 3:246 8:254 --ILVSNDDGFRAQGIRELAEALRPLGNVTIVAPDGPRSGASAAITSTLPIKlhREEGYTVYSCTGTPVDCVKLAMNTVFKekPDLLVTGVNHGNNAGICVIYSGTVGAAMEGCVCDVPALAVSLDDHsdMSHATAYAVHVSRMILKNGLPQDTMLSMNVPK---GKPLGLKPCAVTDGRFVDEYMASEDARGNAVYWMTGRQINKGTIEG-DLELMHAGYVTLSPIKLNMTSRRYLPVLEELLKR-------
101 UniRef50_Q390V3 5'-nucleotidase surE 1 n=23... 260 4e-68 1 34.8% 2:245 10:259 -RVLLTNDDGIDAPGLDVLEQVATQLaeVWIVAPAEDQSGTSHSLSLHEPLRVHRKGDRR-FAVRGTPGDCVAIAISHLMKdrPDIVLSGVNRGGNLGTETVFSGTVGAAMTSMLVGVPAIALSQAFTDrwDTALALAPDVIRRLVAAGWDSDACLNVNFPPRPAQDVRGLKVTNQGAGTLQgeIVSGRDPRDIEYHWLKLARAPRDDDADSETVALGEGYVAVTPLKFERTHDQALARLRTSLG--------
102 UniRef50_Q1MQB1 5'-nucleotidase surE n=1 Ta... 260 4e-68 1 35.1% 1:242 1:247 MNILLTNDDGIHASGLRAIYNELVKLGhvFPFAPTVERSGASNSVSLNVPLTTQDvgDFKGTAINGTPVDCVKVGLAKLHENPPDLIISGINAGHNVGTDILYSGTVAAAMEGCVAGIPSIAFSRPREepTQSYAEHAANLLKKIDFSLVPKGQILNINYPSISIKKTLGIKVCAMSTQGWEHKLHKKKDDNGKPYWFISPYIPYSHGISQTDVFFLLEGWITITPLMFNMTAQTTLSNLEQ-----------
103 UniRef50_C9LFQ8 5'/3'-nucleotidase SurE n=1... 260 5e-68 1 32.1% 3:242 9:254 --ILISNDDGFFAKGINFLIDTLKDEADIIVVAPDSARSGYALAITSMLPVQAEMLKDEevYACTGTPGDCIKLALNRLVERKPDLVISGINHGDNSSVNSHYSGTMGATCEGALQGIPALAFSLCDHRdfQPLKTYILDFYRKALVWRFPPFTCLNINFPKV--DKFAGVRICRMARSRWINEIEdeRNGYSAKYYWLSGSRQSLEPeeDTDIWALSHDYVAVTPTTMDNTAYDFVELLRQ-----------
104 UniRef50_C3XH30 Stationary phase survival p... 260 5e-68 1 35.0% 1:243 1:278 MkiFLTNDDGYFSQGLIALRNALSDIARVVVVAPAHEKSACGHGLCVSKPLQLIELEKDFYKLDDGSPTDCVYVGLCELfhTKPDLLISGINIGANLGEDTTYSGTVAGAMEGALHGIQSIAISQcaNRDFTLALDTIRQLSFDILHNNYTIGhlLNINIPAISKDECKGIKATQLGYRIYNSKAQVMQNPRGQKYHWIGLNPLQWQERDnsDFDAVANNYISITPMQLDMTDYACMQSLHSY----------
105 UniRef50_B6YRQ5 5'-nucleotidase n=1 Tax=Can... 260 5e-68 1 33.3% 3:242 9:253 --VFITNDDGIYAKGLNELIKGFRKIGEIVVVAPEGARSGMSGAITSLNPVRirKEEDLTIYSCSGTPVDCVKLGVNSIVSRKPDLLVAGINHGSNAAVCVIYSGTIGATLEGCIIGIPSMGVSLTDHsdFSQAVKYGKLVAEKVLLEGLPKGICLNLNVPSI--SDVKGLKICTQTKGNWQEKIEKLKDPYDRVIYWLGGEFANEE-PENtdEWALSKGYAALVPLQVDMTAHYFYELWKK-----------
106 UniRef50_C8WX33 Stationary-phase survival p... 259 6e-68 1 31.2% 1:240 8:254 MRMLICNDDGIQAAGLFALVEVASTFGEVIVAAPDRQRSASSHGISLHRTIRVERREVPgaFALSGTPVDCCKWALAVLHAERpdLVLSGINAGANLATDVLYSGTVAIAGEAALQGVKALALSHVGPpdFASAQEACRLLIELAIELDLPADTFLSANIPFVGRKTWTriVWCDLGVRRYHDIFSRELDVEGHEVYRYGGDIIDEAGEGLVDIGVVRSGKISLTPLRYHFTNDQFLHDM-------------
107 UniRef50_B5Y821 5'/3'-nucleotidase SurE n=1... 258 1e-67 1 36.9% 2:242 3:250 -KILVANDDGIFAEGINILVTHLLKWgeITVVAPDRTKNATSHSLTLDSILRLRKvgYEGYTVVDGSPADCVLVALNDLVPDT-DLVIAGINHGTNCGIDVLYSGTVGAASEGVVNGKPSIAISSESPehLEITAQVLISLLDQGLLNATSSDWVLNINVPALKLEEIKGVAWATMSRHGWTNRVQRREDPRGQIYYWVTGERSKPEQSNNGDYQLLSQGFVTLTPVGLDLTDHESLKELSS-----------
108 UniRef50_C1I8T3 Stationary-phase survival p... 257 3e-67 1 34.6% 1:246 1:251 MKILITNDDGINARGIIALAKEISKKHEIIVVAPREQKSASSHSISINNPIKIRedENFKAYSLVGTPADCTQAGLS-LLGGDIDIVISGINRGLNCGTDILYSGTVSAAVEGAIYSVPSIAISMdeDEDYSKAAKWISKILDVAEKGYLKENVVLNVNVPNINEEDIKGLKVCRLGKSTYKTNYILVEENEDKVYVTKGTRNDILED--DSDLYFLSQGYVTLTPLHFDFTNFKILDEVKDIFED-------
109 UniRef50_B6IS03 5'/3'-nucleotidase SurE n=1... 253 4e-66 1 34.8% 2:234 11:249 -RVLLTNDDGIDAPGMAALARVAQELAevWIVAPEHDQSGMSRAISLHDPLRLLGKGERR-YAVTGTPGDSVIVGLREVLatPPDIVISGINRGANLGQEVAYSGTVSAALTAKLLGVPGIAFSQAFRdrWHTAMAMIPRVFEVLDGLGGLPEAVLNVNFPDVEPEEVTGFAFTRQAqnIVAIDTERRTDTRGIDYRWLSFRRAASEQPEDSDIAALRRCAVSLTPLGFDFTDT-------------------
110 UniRef50_A6LS61 5'-nucleotidase surE n=14 T... 251 1e-65 1 33.1% 1:245 1:252 MNILITNDDGINAPGIIALAKEISKEHKVTIVAPKDQKSASSHSISIHSPIKIKEelDCKAYSVSGTPADCTQVGLS-FLKENIELVISGINKGPNVGTDILYSGTVSAAIEGTIYGIPSIAVSMddDEDYSKAVKWAIKVLDIAKEEYLKSDVVLNLNIPNFNERDIKGIKVCKIGRSTYKTEYILLESNEEGDLYTTKGTRNAIKEEE-SDLYYLYQGYVTLTPLHFDFTDFAILSDVTKIFE--------
111 UniRef50_A1B5M1 5'-nucleotidase surE n=43 T... 251 2e-65 1 32.9% 1:246 1:263 MRILITNDDGINAPGLETLEAIATeaGEVWTVAPAFEQSGVAHCISYVHPTLIAELGPRRFAA-EGTPADCVLAAIADVmdNPPDLVLSGVNRGNNSGENVMYSGTVGGAMEAALQGLPAIALSQYmdDPFQAARMHGPRLIRQLLDYGDWTSdfYNINFPPCDAGSVKGTRVAPQGRRQGVreVEPYHAPNGRRFLWVLGGSQTAEATPESDVDANMRDYISLTPMRPDLTCHKTLAELRGVLEE-------
112 UniRef50_O27484 5'-nucleotidase surE n=5 Ta... 250 2e-65 1 34.6% 1:243 1:253 MKILITNDDGVNSSGIIAARRAVEDLGETIIVAPATQQSGIGHALTLFEPVRVSEvdGSGAYAVSGTHTDAVIIGIFELMDEKPDLVISGINMGENLgsELTTSGTIGAAMEAAVHGVPSLAVSLQVRrdFSLAAELTGRVASRILRRGLPEGvfLNLNVPSHPASD--EIRITRLGDRMYNVHIKKRLDPRGRPYYWIDGDPA------GTDFRVQMSTHLRltPPPSPPYHSTAQQALTQW----------
113 UniRef50_C0ZGV3 5'-nucleotidase surE n=1 Ta... 250 2e-65 1 31.0% 1:252 1:263 MRILVTNDDGIDALGIKRLVEALLTlaEVSIVAPVEEKSGVGHGITYRSALSPEQRdpVKAWAVNGNPADCVKAAYHLLFekKPDIVFSGINVGTNLGRDIYYSGTCSGAREAVILGVPGVALSYDNwdNYGDVVEMIRPLVKEFSDRalASEVFWNINIPHVPLAEVKGMVPATLSMNHYEDKYSEEAEG----YYLAREYPQVMPLAEPLDYDLLKHGYIAITPVHIDATDRTLLKQMDNWALLKAWGKQ-
114 UniRef50_A0L4K6 5'-nucleotidase surE n=1 Ta... 249 8e-65 1 35.4% 1:243 1:245 MLILLTNDDGIASPGLQALKDALKERHDVVTLAPVKDMSGTAHAISRGEDIKLTRIAEYEV-AINGTPTDCVMAGLRMVLRRPPDLLVSGINMGANVAEDLSYSATAGAAWEGALSGIPSMAVSLCGSahFESAIKVTHMVIRQWLENPLPPGTFLNVNVPNVPEYELKNPKPTRQGLRF--NWPPPPVTAAGNPAFwtIPTPREEEFQLATDEEALRDGFTSVTALHCLFRHPHATERLKAW----------
115 UniRef50_Q04Q98 5'-nucleotidase surE n=6 Ta... 248 1e-64 1 33.9% 1:245 1:246 MNILITNDDGIASSGIKALEAVLQKEHDTFLIAPLRERSATSMALSIYDSMRVERINDNH-YIVDGYPADCVNIGLHGDIFPRIDLVLSGINRGVNMGHDIHYSGTVGAARHGAVHSRLSLAVSSGntKDYDYiaEFVRHFIDE-YSSLLKVGVVYNMNIPFDFVSSMENLRITRLGKRTYEDTYSKKNIIGGIADFYLGGSKLEHATEEGTDFTAFFSGKISLTPLSLDQTDISLVQELSDTLS--------
116 UniRef50_Q53W92 5'-nucleotidase surE n=8 Ta... 248 2e-64 1 36.6% 1:238 1:238 MRILVTNDDGIYSPGLWALAEAASQFGEVFVAAPDTEQSAAGHAITIAHPVRAYPHPSppAYRVRGTPADCVALGLH--LFGPVDLVLSGVNLGSNLGHEIWHSGTVAAAKQGYLFGLSAAAFSVPLNGEvdFAGLRPWLLRTLETLLRLERPFLVNVNLPLRP----KGFLWTRQSVRAYEGVVIPGEDPMGRPFYWFAPRPL-KEAEEGTDRWAVAQGFVSATPLRLDLTDETRLQ---------------
117 UniRef50_A9GFF6 5'-nucleotidase surE n=1 Ta... 247 2e-64 1 43.3% 1:233 1:238 MriLLSNDDGYSAPGLTAVRDELARHADVVVCAPAVNQSATSHSLSLHRVLRLLEAA-PGVFAVDGTPADCIYVALHavLPRRPDLVVSGMNHGLNLGADIFYSGTVAAAREGALRGVPSIALSADAGASLPAAAALGVKLALALhqEGRRPAPLLNVNIPAGSSW---PVRATRMGARLYTEEVIFRRDPRGHEYLWIGGAGVRHDLVPGSDTEAYDAGAVSVTPLTLDLFA--------------------
118 UniRef50_C7G5W8 Acid phosphatase SurE n=1 T... 246 6e-64 1 35.3% 1:224 1:229 MRILVVNDDGIKAPGIKRLVQMAAGLGEVWVVAPAAQCSAMSHRITVRGDLEVKPYdgVTAYSVGGTPADCVKVALGCLMTEKPDIVFSGINAGYNVGRDILYSGTIGAAMEALCWGVPAIAFSVAEEDECEVLNTYLEPVAKELISKTLPQNEIWNVNFPGCTLEEYKGILWDRiqNQYYRDNYKRTDRPDGSCIFSAAGLP-ETEAADGTDAGAVLSNYISI-----------------------------
119 UniRef50_D1BMX3 Stationary-phase survival p... 245 1e-63 1 30.8% 1:247 1:253 MHILMCNDDGILADGLRHLASYLSQYYRITVVAPANEQSAKSHALTTEVPLKLdeDENPRLYALTGTPSDCMKFGLSYLldDMPDLVISGINHGFNLGSDVLYSGTVSAAMESGFYGIPGLALSVERyeRGDEMYPFIHELIKKIYVAGQFSG-LLNVNFPLRGTCDWDHFKMVSQGLQTYSNIIEARINSRGQDYYWLAGELDYGAESVPTDVEFARKGYITGVALTWKQQCDTDMKRVQNILDEI------
120 UniRef50_C9M508 5'/3'-nucleotidase SurE n=1... 243 3e-63 1 37.1% 5:241 3:248 ----VTNDDGISAPGLDVLVRAFQAEGEtsVVAPSRQRSLCGHSMTLGRPVRLEPVdgVRSWQCDGTPTDCVILAFDGLGLSD-GTVFSGINDGANLGDDVTYSGTVAAAMEACLTGRQAVAVSVVTpvHYETAGAVAVAVFRQLRKSPLPGGVFLNVNVPDCPKDELAGIKICHQGQrrYGGMIRRHEENETGVSFWLEGRPHDEPQ-PGCELWAIGRRCAAVTPLGLKFTHGAALEQLR------------
121 UniRef50_A9NG37 Predicted acid phosphatase ... 242 6e-63 1 35.8% 1:240 1:240 MNILVVNDDGIDAEGLHILTKAASYHGSVYVSAPKVQQSAKSASITYTGYIEVEEIEpvRTIVVDGTPADCVRLGV-KVFEQEFDLVVSGINDGVNLAIDVQYSGTVAAAFEASIMGLNAIAFSAPdpYIFDETIKLLDEIIEN---KLYLETDILNINYPHASFKKVLGTRITKMGLRIQHSEFIKTDKPN---TYRILGSNIFVKEDEDADMTAFNEGYVSITPLKMDRTDYKKIEKL-------------
122 UniRef50_B3T8G7 Putative Survival protein S... 242 8e-63 1 34.5% 1:249 1:266 MKILVINDDGITAPGIWAAARALRQVGEVVVVAPDRQQSGVGASLTLHAPIKADPWspVSAFSVEGTPGDSCILALETLVKD-VNLVVSGINAGSNVGWDVMVSGTVGGGLQGFIRGINTIAISVatNTKYDIAEKILKPLAEKFKDYSG-DTLFLNVNIPKIEMSQVAGVRVTRMGGRSWGENV-RAENVGPEKRYWISRNKSISDTppDSDIAALKNNCISITPLRLGLGNDSAMPALESLLGDIPQ----
123 UniRef50_Q1J2E1 5'-nucleotidase surE n=7 Ta... 241 2e-62 1 40.7% 2:247 11:261 -RILVANDDGIFSPGIKALALALADVGDVVVVAPDVEQSAVGHGITIRRPLRFKhfGTLPAYRVDGTPADCVVLGVHLL--GRPDLVVSGINLGSNLGDDLTHSGTVAAAIEGLALGLPSIAFSQQGNgsFTAGAAYAARLARAVLAKGLPPRVLLNVNFPAGLP---RGVRITKVGEHRWEDSIITRHDPEGREYHWVAGQSRAADadPDTDYGAVQAGYVSVTPVRLDLTARDLLGELAGYVPEI------
124 UniRef50_Q1QD10 5'-nucleotidase surE n=1 Ta... 241 2e-62 1 38.1% 1:244 1:268 MKILMSNDDGVYAPGLLALYEALSTMAEVMVVAPNSEQSGCASALSITTPLYTHQL-PSGFIAVNGTPADCIYLALNEIydTDFDCVITGINSGANLGQDVLFSGTFGAALTAQLFGIPAIATSLVgeRHYQMAAS---EIVKLLTDTPILDIcvLNVNIPDVsaDEINGRKMTVLGHRKIARPVHHVVDPRGRDAYWLSLRKRqsSGTTMTDDQAVAAGYISLSPVRLHHTPAATLDMLSALM---------
125 UniRef50_B9E0C7 5'-nucleotidase surE n=2 Ta... 239 6e-62 1 33.3% 1:246 1:244 MRLLLTNDDGIMAEGIQVLAKHFEKDNEVIIAAPDVQRSGSGHCItvPGELIIQEVknSKAYSITGTPADCARLGVRKLGNNQIDMVISGINNGFNLGIDSLYSGTVSAAIEAAICETPSIAVSLdgNYDYNIAAEYALEVFSIYKdkNKDENVVLSLNVPCLPREKIKGLKVCRVGFKYHLQEIYDK------------GEKTEELSYNYTDIYYVKRGYAALSPLHYDLTNYKILGDINNLFTE-------
126 UniRef50_D1VSZ7 5'/3'-nucleotidase SurE n=1... 238 9e-62 1 31.0% 1:245 1:249 MNILVTNDDGIMAEGIRTLAKVLIDKGhvTIAAPNVENSGKSHAITFKTPLVVQNIegVKAYSVFGTPADCVRAAVH-LCDKKFDYCFSGINSGYNAATNVLYSGTVSSAIEANLFNIKSVAVSAsgQVNYQSAAKIAMELFDKIKDENILQ--VYNLNVPFLNYDEIKGIKVAKVGKDVMS---IYDISSEGNEylKLKGFPKEFNGDKDSDIYYLNQGYATVSPLYYDTTNKTSIDHLKEILD--------
127 UniRef50_C9RKP8 Stationary-phase survival p... 238 9e-62 1 30.6% 2:246 8:267 -RVLITNDDGVGSVNLHALALALSEVSDVYVFAPEDEQSGVGHAFTIRRGLRVQHVepYEVYSVSGTPADCVKFAVGhiVPEGFDVCFSGVNVGENSGVSSLYSGTVAGAREAALWGVPAVALSLRggNLLQVAIDFARKIVSENLFKKISKGVFWNVNFPKIKEDEFLGFKACTMDRGMFTDHYDHK-----DGLWFLDGEKLWSMAPEGSDDNLLDKGYATITPHRIDQTDEESLEVISEMLGS-------
128 UniRef50_B3CLR5 5'-nucleotidase surE n=9 Ta... 238 2e-61 1 28.9% 1:242 1:239 MIILITNDDGFESEGIRLLKEIAQNFaeVWIVAPDADRSGAARSLDYpqFIKISQHSERE-FSVSGTPADCVIIALNKIMNKKPDLILSGVNIGSNVGDDICYSGTIGAAMEGAARSIPSIALSQVYHddWNNTKIFAPKVIAKLMKVGWPKDIVMSINFP--ATEKVKGVEFAEQGEYNIDGDLTFTENLNGS----LSLNWSREHSGSGS-VDKIKGGFITITPIKLDFTDYDILNAMKN-----------
129 UniRef50_C0FND5 Putative uncharacterized pr... 237 2e-61 1 33.2% 2:224 36:263 -KILITNDDGIQSDGIIRLARAAKKYGKVWVVAPDGQRSAMSHRITLHETIEffPVEGVHAYASTGTPADCVRFGILNIVKEKPDYVFSGINYGYNSGTDIQYSATVGSALEAACAGVHAVAFSEGASECHEVTDAYLERMMEELMEQPLAYNQIWNVNFPQCELEKLRGikIADCG--FFIDEYLEEELENGRIRLTVHGNYNE-NAPEGTDFRALVDGYISV-----------------------------
130 UniRef50_C6XFK1 Stationary phase survival p... 237 3e-61 1 28.6% 1:245 1:249 MRILLTNDDGIKSKGLITLENIARSISdiWICAPEMDQSCLANSLTMSRNIACRTISKKR-FAVHGTPVDCVVIALQKMSDKKPDLILSGVNVGTNTSNHVAYSGTLAAAFEGSLQGIRSFALSQAYtiPWEVSETHAPRVLRQLLKTQIPNTTLCNINFPRCSPEEVQKTVVTAQGKPCFSIDAKQISTNDNMSHYCLTFGDHLKNLCEKSDAFAIQHNMISVTPITTDLTDYNSQQYISLSLE--------
131 UniRef50_Q3YSH3 5'-nucleotidase surE n=5 Ta... 237 3e-61 1 30.4% 1:240 1:247 MKVLLTNDDGFHATGIKVLKEIIIESgeVWIAAPASNCSGYGRSIGVKTATDVYQIGDTE-FIVNSTPSTSAFLGLREITGKKPDLVLSGINSGINVGNDIGYSGTIGAAAEGAMMNIPSIAISQegEINWINPQKFLKKIINMLLEVPFwkSTIMNVNFPLVPA---KGIKFTSQGEYIPSNKIEKKRNVSGSISYTVHRIAPDKGNRGYSdiKAIDDGYITITPLKLDMTDFDALESL-------------
132 UniRef50_B1L691 Stationary-phase survival p... 235 2e-60 1 32.8% 3:231 5:253 --ILLTNDDGIHSAPFRALWIAlaKIGKVTVVVPEHEMSAAGKGITLHKPLRIRkfGYREAFTVSGTPGDAVTVALKFIMNSTPDIVVSGINVGDNITLDNltSGTIAAALQASIMGIKSSAFSVEIpdRFLTHARIAAKITDWILRRGMPEGvlLNVNFPYRVSQD-TPIRITRLARAKYENYVLERIDTRGNPYYWLGGNppVTEKDRGTDLYALteRAISITPITLEM----------------------
133 UniRef50_Q0F8M6 Survival protein SurE n=1 T... 232 8e-60 1 30.9% 1:243 1:251 MKILITNDDGIDAPGLAVLYKilTSAEKILTVAPATEQSGVSHAISYHSSINLEKITKNR-WACHGTPADCVIVGISE-YNQKFDLVLSGVNRGNNAGQNTMYSGTVGATIEAAMNGIPAIALslDNENIFDAVSMHGLKTIQNIlwNNNSAPIHYNVNFPPCLGIDVTGTSFTMQGYRTGAP---FSTETSNELLKIKGLPQQQEDTGSGTDINANINGKISITPCSVDLTNHAVLRELLKL----------
134 UniRef50_A6G4W5 Stationary-phase survival p... 231 2e-59 1 42.4% 31:247 3:215 ------------------------------VCAPTSERSGFSHAITLRSSLRSEPAPEFgwYAVSGTPVDCVYLAALHLCERPPDLVLSGINPGYNLGADVFYSGTVGAAREGLIRGSSALAVSVEPGGAPQLAAPFVRTLVPMLLERSAteRHLLNLNVPCEAHG---GLRVTRLGHRRYEDKVDERQDPSGRPYFWIGGPPAEHDAGATEDLGAVAEGFAAITPLELDITA----PEIDDWARAL------
135 UniRef50_A3MT21 5'-nucleotidase / 3'-nucleo... 231 2e-59 1 31.2% 1:231 1:239 MRILVTNDDGVYSPGLRLLYQFAEPLGEVDAVAPETPKSASGLGITLHKPLRMYEMdgFKVVATSGTPSDTVYLALYGL-GRKYDLVLSGINLGDNTSLqvLSSGTLGAAFQAALLGIPAVAYSLYAES-WdeALHVLRAVvrYVAERGMPQGvvISVNFPQRPRRGVR-AKLAKPAKLRYAQRVEARRDPRGAAYFWLYGEPLS--PEPETDVYVvkEGNVAVTPLALNL----------------------
136 UniRef50_C7GZ44 5'/3'-nucleotidase SurE n=1... 230 5e-59 1 34.7% 7:242 3:245 ------NDDGINAKGLRALADEISTIADVYVVAPDGERSAMGHCISCRDKIYLESQDFPgaYKCSGTPADCVKLGIDFlmDIEMDFVVTGINHGGNLGTDTHYSGTVSAALEGVMNKVSSIAVSVVSHEafDYPAKLAKdvLGRF--GSIPNDRMLNINVPDKPEAEIKGIKFTKLGRRGYVDIFKRLPDENGKFCYTYSGNPRHYGTCDDedVPAFEMGYVTVTPMGLDFTDHEMLSDINK-----------
137 UniRef50_D2EF06 Stationary-phase survival p... 228 1e-58 1 26.8% 1:246 1:259 MVVLITNDDGYKTEGLHTLYRAAKKvsEVMVVSPDKLQSSSGMSFTFHKPLRVEKikGMPCYTVSGTPADCVFMSIYHLFKNKVSMVLSGINEGMNAGLETVysGTISAAMFAAISEVPSIAFSKNLSVdmKSSYESVVKILENIKTKKFPRNimININLP-LKINKKTEIKIVKTDKRVFDDIVIKKKDPNGKDYYWLYGT-LRKDLDKDADLYNLFNQKITVTPIKLSTTEELHIKTLKDIFHN-------
138 UniRef50_A6F5B1 Stationary-phase survival p... 228 2e-58 1 30.8% 2:238 14:251 -RILITNDDGINAPGLAILERIARNLAevWVVAPEHDRSGAGQSISIHDPLRVYENGEKR-YAVSGTPADCVLYSLAHWfeNPPDLVLSGVNCGANISDSVQYSGTVGAVLSAEHMGIPAIALSQaeGVDWSPVSVFGEQVIRKLWQPG--ENRAWNVNFPACDAGVIRQAQWCNQSTgiQQPRLLAGQDARSLPYWWLGFDRSSRhtAPDEDVTVLREKAIAITPLR----HREALP---------------
139 UniRef50_Q08W51 5'-nucleotidase SurE n=1 Ta... 227 3e-58 1 28.2% 1:248 1:261 MRILLCNDDGFLAEGLRTLASELTQHGhvTIVAPSAERSGQSHAMTFFEPLLVRHVSHQ-VYAVHGTPADSAFIGLRGVLGkpPDLFIAGINHGLNVGIDVNYSGTIGAATEASLLGFRAMAISMDVDpaFQRTARLAAELIGHLHRLDWAPQEMLSLNHPGHEPRGLVAAHCHPDCIYVPheHLASRTHSREdqVYVIGGTTRATPQDGEHDVAALQAGYATLSFLQTHQGHTPGTSRLRPFLDMLR-----
140 UniRef50_D2LKR1 Stationary-phase survival p... 226 7e-58 1 35.1% 41:245 12:223 ----------------------------------------AAHSLTLHEPLRLRKLSERT-FAVKGTPTDCVIMGVRHVLTDkpDLVLSGVNRGSNVADDVTYSGTIAGAIEGTLLGIPSIAMSLadRIYWQTPMQLGADLVRKMLDAGWPKDVFLNVNFPDREPERVECIKITEQGRRDPdlRIEDRMDTRNNPYYWLGFKPMSMITGEGTDLHAVKSGAISVTPLCLNLTHRETCRKLSAFIE--------
141 UniRef50_UPI000038E0AE acid phosphatase SurE n=1 T... 225 1e-57 1 29.5% 3:229 2:239 --ILVTNDDGFNAAGIKQLYKNASMVDDAVMVAPDSMRSASGMSITFTRPMRIQSLegINGYCVSGYPADTITVAQNIIlgKKIDLVASGINIGSNISLRSIysGTISAAIAAALKGIKSIAFSMVTdpDFSKAGMYSRYIIEEFKKSGFPEndILNINFPAQITDE-TEIKVVPMAENVFHDYLEHNVDPNGKDYYWL-GNTVEKTQDRNTDYYVleENNISVTPLSV------------------------
142 UniRef50_Q6KZ11 5'-nucleotidase surE n=1 Ta... 222 1e-56 1 28.7% 3:253 2:244 --ILVTNDDGYNSYGIRVLYRAAASIAESYIVAPDHGRSATGMSTTYNVPLRAFKFDYG--YAISGFPADSVYMARYALydKKIDLIVSGINHGDNISLRSLysGTIGATMAGALIGIKGIAFSMssNEKIDLAEPYIKAIIENAMERFPDDVDILNVNFPGNLNRN-TRILPARMSYNIFDDNIIKRLDPNGHEYYWFGNKRHER-CPENCDYDVvrKNSISITPIT-----------VKGYLDDLRSTEEF
143 UniRef50_Q2JLL2 Acid phosphatase SurE n=13 ... 219 6e-56 1 31.9% 1:229 1:237 MKVLLTNDDGIEAAGLANLKLALSAleHCWIVAPHQPISGCSHQVTTGRPFRALARGERT-FAVEGSPADCVRVALFKLA-PAVDWVLSGINEGGNLGSDVYLSGTVAAVREAAMRGIPGIAISQyqPIDWEQAQRWTREILAELMEQSLPRGAFWNVNLPHLPAGSPLPERvcPLCTQPLPLDYAVEAEGNGAESLWFrgRYAERARDPQTDTDICFSGRVAITQVQL------------------------
144 UniRef50_D1HYN3 Whole genome shotgun sequen... 217 3e-55 1 30.3% 2:229 12:280 -KIMVTNDDGIDAPGLRALVQVltNLYEVLVCAPDSEKSAVSHSITWIHALAVKRVegATAYAVSGTPADSASLGIStlFPSIPDLVISGINMGSNCGYHIVYSGTVAGAREAFLNGIPSVSVSYNWVadFKLAAEACLPMISAVlnQRYPERCFLNIDLPTDVVNH-KGYKLTKQGKSRVkpEVCTEMdprgEHLLFKREVRGAPVLEDDTDYQCLLEGYITVTPLGA------------------------
145 UniRef50_A9WCM3 Stationary-phase survival p... 216 5e-55 1 36.4% 1:228 1:244 MHILVTNDDGIDSPGLWALAKAMRAAgrVSVVAPAEEQSAMSMALptNRELRAieLDGMLAFAHNGSPVGCVTVAMLSGVLPPIDAVVAGINRGLNGGSNVMLSGTVGAAMIGALWGLPAMAVSLQypMPWATAAYVAERLFPLLEQIRGQAPLVLNVNVPHVapDDLRGFRQTRLSEFFFGHYLDIELNPTgsQIIFRFARERVPDFDVDTDDGAVRAGYVSITPLR-------------------------
146 UniRef50_A2BLQ8 5'-nucleotidase surE n=6 Ta... 216 7e-55 1 29.3% 2:230 6:245 -KILVTNDDGIHSPGLRLLYEAVKELGRVYVLAPETPKSASGLGITLHKPLRIGKvgDTMVYITNGTPSDVIYIAIEE-FSPRFDVVVSGVNIGDNTSIQvlSSGTIGAAAQAALLGIPGIAFSAddRETWENMKRVIRAITSWVLEHGMPEGvlISVNFPRKVRKDTK-VKIAPAARIKFLQKVSVLYDPRGRKYYWLYGTLV--EPEPGSDVYVVheKAIAITPLSLN-----------------------
147 UniRef50_C9LM69 5'/3'-nucleotidase SurE n=1... 216 7e-55 1 30.9% 1:243 1:251 MHIFVTNDDGVAAPGIRALARALSALAKITVIAPAEGVSSCSSALSLRKPMKLKKreNIEVYSLTGTTGDCCKLALEYWLKDdpDLIVSGINDGFNTGSDCLYSGTVAGALEGIFAGIPSMAVSMESMAdlRETAAFAADLVsyFMKKRY--TGILNVNIPKIKPEkwENVKVARLGLLRYSNVIAGKRTKADEMEFIMRGKPLER-YEPETDVYWSRKGYITITPLQWNQTDFENLREVGKL----------
148 UniRef50_Q3KME4 5'-nucleotidase surE n=11 T... 215 9e-55 1 28.9% 1:246 7:268 LRILITNDDGIKAKGISLLISLLREaaDLYIVAPLEEQSGRSMAFSLVEPTTLEPFDYpeAWAVTGTPVDCVKLAIGELFKENadLILSGINNGKNSGRCLYYSATVGAIREANLHGIPAIALSQSENIAfaHMASLIRSLCEFTVAYKHTDPLGLNVNFPASTDDswKGIRFTLSGNEFLFGIPRLVRTEGNRRYYTLYDMRDKVSEEFSEEYLALANNYISAAPLVSKNTPRATLSelKDSFEQ-------
149 UniRef50_Q114P0 5'-nucleotidase / 3'-nucleo... 215 1e-54 1 30.8% 4:224 6:226 ---LITNDDGIDAPGIRALHKALSQVtrIVMVAPKHHQSGCGHQVNIRTVIPVEWRSETEV-SVDSTPADCVRLGVNYLYDD-INFVVSGVNSGCNMGSDIYPSGTIAAAREATIHRIPAIAFShdWEIDWERAIQWTVMVLKKLLAEPPEEGTLWTVNFPHLEPDAPEpmVFCRLCNRPLLTEFVKKENG-----YLYVGYDLNRKSDPGTDVDVCLSGNIAI-----------------------------
150 UniRef50_D2RQ51 Stationary-phase survival p... 215 1e-54 1 32.0% 1:247 5:262 LEILLTNDDGIDSTGIRALYDALSELGNVTVVAPATDQSACGRSMSHEVDVDDRELG----YAVHGTPSDCVVAGLAEL-GPFPDIVVAGCNEGANLGEYVlrSGTISAAVEAAFFDVPAIATSMyhPEDFAEATRVTSYLVENALEAgfDHAAYLNVNVP-LADGDPAPLEVTRPSKRYEMDAERDGGRVHLKDRVWERMDPETLPDPDGTDRRAVVEGRISVSPLTAPHsrHEGLSALADAYSET------
151 UniRef50_Q8YSE9 Putative 5'-nucleotidase al... 213 4e-54 1 31.4% 1:229 1:226 MTIILTNDDGIDAPGIKALAQAVSGK-NFIVAAPRDHQSGCGHQVTTTRPINLQRRSDSE-YAIAGTPADCIRIAITQI-SQDVKFVLSGINAGGNLGVDAYISGTVAAVREAAMHGIAGVAISHyqNFDWELAAKWTAEVLEELLHRPLEPGYFWNVNLPHLQPGETQplVFCQPCTKPLPANY--RID--GDDFYYVGEYGK-RERTPGSDVDVCFTGNIAITQLRV------------------------
152 UniRef50_D2RQN3 Stationary-phase survival p... 213 5e-54 1 37.0% 2:247 8:277 -HVLLTNDDGIDAPGIRALYDALTEVATVTVVAPDRNRSAVGRSLSYGRtlEADGFTSPvgYAVDGTPCDCAIVGVNAL-EPRPDLVVSGCNSGANLGAYVFssGTVSAAMEAAFLGTPSIAVSMDtpADFAHTGEITAALVEGAPGTGldRVDYLNVNVPR-PDVESEGVELTRPTEVYEMDAALENGEFQLTNRLWQQMANRDIPDPEDTDRHALLEGAVSVSPMRVP-YDVVDTDAVRTILEDV------
153 UniRef50_Q7XB62 Os07g0204500 protein n=5 Ta... 213 5e-54 1 33.5% 3:229 17:286 --VLVTNDDGIDAPGLRFLVGQLVAayRVLVCAPDTDRSGVSHSITWRPALRCKRVdgATAFAASGTPADCASLGISGKLFdvPDLAISGINVGNNCGCHVIYSGTVGGAREAFLYGIPSLAMSYDWVadLKVAAEVVMPLINNVMAetYPQGSFLNIDIPTDAAHH-KGYKITKQGRYmwEQTVYKktSSENDLLFKRVLVRRSYDEEEGDDIdcLVDGYITVTPLGA------------------------
154 UniRef50_P73440 Putative 5'-nucleotidase al... 213 6e-54 1 29.3% 1:229 1:225 MNFLLTNDDGIDAPGIEALYEALGKRG-VWV-APKNQHSGCGHKVTTDQAIAVEQRGKNR-YAVDGTPADCTRLGVVHFYPE-VDWVIAGINAGGNMGIDSYLSGTVAAVREAAILGHKAIAISHWINknWAWASHWANAVFNTLWQQDLPPQHFWNVNLPHWQSGDPEpvIFCEPSR----DPLPVAFTIEGSNFFY-RGEYSQRPRQPGSDIDVCFSGNIAITQLRV------------------------
155 UniRef50_Q823A7 5'-nucleotidase surE 2 n=1 ... 211 2e-53 1 27.9% 1:229 12:252 LKILLTNDDGIFAPGMTLLVSNLLKaaDLYIVAPKTEQSAKSMAMTFHEPVILQPYDYpgAWSVSGTPVDCVRIALAYLFKDepDLVLSGINRGSNAGRHVFYSGTLGAAIESTLCGVPAVALSQEGnkNFDIPEMLKSLSLYALSLPFAPHPVALNVNFPAS-NERWKGMRFVTTGPEYSCGVPHFLFCDGDSKIFKLSGGPKIVEEIPSEEWQTLRASYIAVSPVMA------------------------
156 UniRef50_UPI0001C418A6 5''-nucleotidase SurE2 n=1 ... 209 1e-52 1 32.2% 2:243 3:260 -NILISNDDGVMGPGILASKQALEGLANVVVVAPQENNSAVGRKVNIMKHMYLENYegSMAYGLSGTPADSVNVGINYVCDEVPDLVVTGINPGINISrqITTSGTVCAAIEAVGLGIPAIACSlyVDTDYSFAQKILAKLVKKVLDEGMPDGvlFNLNIPSKPLSD--KIKITRLADSMLKFNILERVDDDGNDTV-MNVPELIEDYEEGTDGYCLleRRPSLTPLNVHFGA--EISNLEDW----------
157 UniRef50_A2R7M7 Contig An16c0150, complete ... 208 1e-52 1 24.8% 1:238 1:324 MHILVVNDDGpsSPYIHSFVQSLQSAGhvSVVLPHQQRSWIGKAhtYFRPGTLHkyDGDEWILVDSTPASCVQIGLYHYFQDriDLVVSGPNYGRntALFALSSGTIGGAMEAAVCGKPAIALSYasSRDHDpaSRHSVRLIEYLHKNWADGVDLYTVNVPLEPGVSQNKVLYTNMLDNRWsqHKHFEWAPNFSDVY-----RSVEEGAPGNDGWAVKEGMTSVTPLRANFMHTPGIQ---------------
158 UniRef50_Q9Z8S6 5'-nucleotidase surE n=2 Ta... 208 2e-52 1 30.4% 1:227 8:245 LKIILTNDDGITAKGMSCLVSALLEagDIYIAAPQAEQSGKSMAISLNQVVCASPYAYpeAWAVGGSPTDCVRLGLRTLFEssPDLVISGINCGNNICKNAWYSGTIGAAKQALVDGIPSMALSQDNHISfdKAPEILKALVIYLLSQPFPCLTGLNINFPTSPGgsWEGMRLVPPGDEFFYEEPQYLGSVNKNQYYVGKISGVRIGEHPSEELACMLENHISVSPI--------------------------
159 UniRef50_UPI00016C49EF stationary phase survival p... 206 6e-52 1 30.1% 1:229 1:227 MKLLLTNDDGIEAAGLHALLTAARGLGEPVVVAPAGPQSGVSHAVTTEGPVRVDARDNR--FAVHGTPADCARVGLHRLCPDA-GLVLSGINHGGNLGADVYYSGTVAAVREAVLHGWTGVALSHYRKrdWPRAARWAARCLTDLLARPRVPGAFYNVNLPHLRPDEPDpmVFCPLDPHPLPLSYRHEGDG-GMRY---DGDYHTRQRTAGADVDVCFGGRIAVTVIKL------------------------
160 UniRef50_B8DSE4 Stationary-phase survival p... 204 2e-51 1 31.4% 2:246 5:265 -RILLTNDDGVHSPGLLAAAEALHPLGGVDVFAPLRQQTAMGRAQTGDRNAILQQVepLRAWACDASPAATVGHGLKVMPGYAPALLVSGINYGENLGASITSSGTVGAALEGACRGIPALAVSmyTEQDWSAAMHFLALFAGMVLERGLpdVHVLKIDVPAGATPD-TPWRLTRLSPDMYYEsaVPSLGSrgDATVTKGPAPGES---PETDVYALsdRVVSVTPLTLDFTARTAFGDIRAWLDG-------
161 UniRef50_A8IGE2 Predicted protein (Fragment... 203 4e-51 1 32.5% 2:229 5:270 -RILISNDDGINAPGIKALVAELVKaaDVYVCAPSGERSAQSHAITLGRYLSCVPTEPTTayAVDGTPADSVMLALCSPVFQdfDLMISGINRGDNAGLHVIYSGTVGAAREAACKGIPAMALSLDNhdDYAVSASLAValPGQEAGGRApkGVVINVNFPIAQGQMLQGLFLARQSLACVFPAFKEVTEAPgsRVFRNYAGMVQEDQEEGNDAYALKNGWVAVTPLSL------------------------
162 UniRef50_A8MBQ3 5'-nucleotidase surE n=1 Ta... 203 5e-51 1 32.6% 1:227 1:244 MRILVTNDDGLTSMGIVTLANELAKEHEVHVVAPETQLSSIGAARTYNRPIRIWRwgPVDVYATDGTPSDAVFMGINM---FKPEIVVSGVNLGENVGLESLfsGTIGAVIQSSLIGVPGIAASIEVPPhfSGIVKVIKGIINHIEAEGWVKGvaLSLNMPSPSRWSGGYVVVSRMAKRLFKETVIESSDPRGNKIYWRWGEEL-MPLDTDTDAYAfrEGKLTVTPL--------------------------
163 UniRef50_Q2GE33 Acid phosphatase SurE n=2 T... 202 1e-50 1 28.6% 1:245 1:252 MRALITNDDGFDSPGLTLLREFVLSIgeAITVAPKTNRTASSHAVSLDKKLRIEEIAEN-VFSVDGTPADCVITAFHDSRLTkpDVVFSGVNIGANLGIDTIYSGTIAAAMQGMLSGTVSFAFSQFYSSSPHtsPHIKKYILSMLEKVDILKNCVLNINIPEC---QVIGVKHVPQypNKRKSAIRARPHEEDNEKYITIEGTSSPQFCE-----FLRSGYVTVTPVGCDLTHYAALKFLDSSFS--------
164 UniRef50_C8SKF5 Stationary-phase survival p... 201 1e-50 1 28.9% 1:253 1:241 MRILICNDDGIEAPGLARLVNAVTGLSdvWVVAPDGKRTAAGSSLTIARPLTMRRVKPN-WYSCSGTPADCVVSAMTWLfeKKPDLVLSGVNDGRNVAEDLAYSGTLGIAREATFWGVPAIGFSRVKNPDfdGDDHWLGTLIASLWqdWTSEGHWLSVNLPTSLPAEIRQPRIGRDKIGRTAEILESDAD----RTVITVPRGRAHASEPGDENAAIDAGFVSINRL--------------NWFGETRLDERF
165 UniRef50_A6RRE8 Putative uncharacterized pr... 196 4e-49 1 24.7% 1:243 1:317 MHILVVNDDGpsSPYVHSLVQTLQAAGhvSVVLPHTQRSWIGKAhtYFRPGTLHEDDGteWVLVDGTPASCVQIGLYHYFKDrvDLVVSGPNYGRntAVFSLSSGTIGGAMEAAVCKRKAIALSFAFfrNHDpaSRIGVKIIEYLYNNWGEGVDLYTVNVPLVEGVEKNKILWTNMLQNYWGehKHFKWAPRFTDVY-----KSVEEAEPGNDGWAVKEGYtiVRPIQLPQASYTLLSSPSDL----------
166 UniRef50_A7BP97 Acid phosphatase n=1 Tax=Be... 194 2e-48 1 61.0% 86:244 1:163 -------------------------------------------------------------------------------------MVVSGINAGPNLGDDVIYSGTVAAAMEGRFLGLPAMAVSITspHYYQTAALVVESLLARLQNdpLPADSILNVNVPDLPLEKLKGMRVTRLGSRHRAEPAIKSEDPQGSPIYWVGLAGPEQDAGPGTDFDAINQGFVSITPLQVDLTRHSALEKLEEWL---------
167 UniRef50_A1RWH2 Exopolyphosphatase / 3'-nuc... 193 3e-48 1 29.6% 1:250 1:251 MRILVVNDDGVG-DGLLALARVAERLGhvFLATTHDQRSGYSKSVSFKATYTPAKIGGYEGIVTNSSPASAVLLA-FKVFGKEFDFVLSGVNMGPNLgwDILSSGTVGAVLEAALHGVPGAAVSLvtYEDYERAARLAVDLLERL--EWRPPCEVLNINVPLRTNGS---VKFT-LPERVPPRDLYRCSGNECRMGYW-TLQESYVCSNPRSDVCAIKEGFVSVTPLSPGSLAREDL--VKKLTRSTSLG---
168 UniRef50_D1S4A6 Survival protein SurE n=1 T... 191 1e-47 1 35.5% 2:229 8:263 -RVLVTNDDGVHAPGIRALARSAYERgdVVVAAPEAEASGMSAALsvFRETELDGLPGVPAYAVAASPAYIAVLAGLGVFGPVPDLLLSGINRGANAGHAVLHSGTVGAALTAGNNGIRALAVSldESRHWSTAADLAATLLPWLA--GADPGTVLNLNVPDRPADQVAGL---RQATLAPFGQVQVSVAERGEGFVRTAVEANAVRAVPGTDIAWLADGYAAVTAIRA------------------------
169 UniRef50_B4WKJ7 5'/3'-nucleotidase SurE n=1... 190 3e-47 1 32.0% 5:223 6:224 ----LTNDDGIGAPGILALQKAVEPLGQTVVVAPDTHLSGCSHQLNRGGAIAIDQRSQTE-YAIGGTPADCSRVAISHLY-PTADWVLSGINAGGNLGSDTYVSGTVAAIREAALLRKPGIAISQYRYrdWPRATRLARKVIRQLMEKPTQPGEFWNINLPAPPldDEPDVIFCNQCTQPLPTEFA--IDETGFRY--IGAYEKRL-RDRGGDVEVCFSGQIS------------------------------
170 UniRef50_Q18F17 5'-nucleotidase surE n=6 Ta... 190 3e-47 1 31.8% 3:247 7:265 --VLLTNDDGIDAVGIQALYQAFDDIAEVTVVAPTDDQSAVGRQLSSDVTIH----EHDWGYGIDGTPADCVVAGVEALC-PDVDLVIAGCNKGANIGAYVlrSGTVSAAVESTFFDVPAMAVSMYIpsAFADASRAATYLARHAFDAgfEQADYLNINAP-VAANEPATLEVTRPSRVY---DMTAEHDGNghDRVWERMRTDDIPDPSGTDRRAVVDGHISVSPLAAPHthHEALDAlsTYLDSI------
171 UniRef50_A5DPP1 Putative uncharacterized pr... 190 3e-47 1 23.9% 1:238 1:288 MHILLTNDDGptCPYIKYLVDEINTATDwsIVIPNQQRSWIGKAHFAGRTLSTTYidYQEWCLIDSTPAACADIGIHHMYETPIDLVVSGPNFGKNSSnyILTSGTVGAAMEAVTHGVKSIALSYAFNsdykEAAKISVKLIEKLYHQlqPQVDLFSVNIPLVESLKltRIHYAPILQNSWNSIYAPNVDDNGrqFLwpDFKKVYKDGLLdtDSRVLLNEGISVTPLRAAFTVTHPLE---------------
172 UniRef50_B6H3Y3 Pc13g10510 protein n=17 Tax... 190 4e-47 1 25.1% 1:231 1:314 MHILVTNDDGpsSPYVHSLVHSLQSAGhvSVILPHQQRSWIGKAhtYFRPGTLHqdEGDEWVLIDSTPASCVQIGLYHYFKEriDVIVSGPNYGRNtaLFALSSGTIGAAMEGACCGKRSIALSYasSRNHDpaAGHSVKLIEHLCANWADGVHLYSVNVPLEPGVSENKVLYTNMLQNTwgNSEKSSSGPrhKHFKWadVYRSVEESEPGNDGWTVKEQMTSVTPLKANF----------------------
173 UniRef50_B9KI89 5'-nucleotidase surE n=4 Ta... 190 4e-47 1 28.5% 1:239 1:256 MRVLLTNDDGFDSVGMRVLRDVVSgfAEVWVSAPARDCSAASRALSVRTPIKTHMRGERE-FVVHGTPADSAVIGICEMtgKRPDLVISGINYGANTGFTVPYSGTIAAAAAAFDIGVPAIAISQQYntSWQNSRKSVMALVSRLLRDTMWhkCIMSINVP---YSDVQGVKfcDDGHIKWDGPSMERRegDGRCvyVFDDMRSPNSNDNASDTQLLEQGYIVVTPIGHSMTDHATLDK--------------
174 UniRef50_Q0RTZ1 Acid phosphatase SurE, surv... 189 6e-47 1 34.8% 1:247 4:283 LHILLTNDDGwdTPLIVALRDALKAAGhvVVVAPGTDQSGQGGRISAPpqLTVARPEPSVWTVTPGSPSDSVFFAFDQVfnAKPDLVVSGINPGNNLGQAVNHSGTVNAAATALEFGVPAIAVSLQTSSTwkSSAAYVADLVARLEGRsmPPGVGLNVNYPLLAGppPRGVRPTTLDTGVALDlyTPTSGQAGQptYTIGLTPNDQAAPAGTDTRAVQDGYVSLTPLEAD---RDVDGSTESWLHRI------
175 UniRef50_A8BAE8 Acid phosphatase surE n=2 T... 189 9e-47 1 30.6% 1:248 19:296 MRILLTNDDGHNFIGLTTLRQIMLDSGhvIVAAPAHDQSGKSQSLHYIKELNVSRV--AHGYVIEGSPVDCVRLGLQ--LHPDVELVVAGINNGANCGSDVCHSGTVGACFEAANMGYHAISYSMDTrsNCKEPVQTTLDaiSYLAQNGSKRqmVWNVNIPA-PHVPVLGCKAAVLGHRYYSVKYAYsiDLLNSSSSWTMRGELDPDSLpeADFDAVEKGWVTVTPLNPDRFHTDEYDSVLRVLSNLG-----
176 UniRef50_A9HDS9 Predicted acid phosphatase ... 189 1e-46 1 30.9% 1:246 1:247 MRILIANDDGIDAPGIALAEEAARKLSdvWVVAPEAKRTAAGSSLTVGRPLFMTETAPQR-FSCSGTPADCVVTAMTWVFKdkPDLVLSGINDGPNVAEDIAYSGTLGIAREATFWGIPAIGMSRVKNPQltDDTDYLARLIGRLwqHWVLYGHWLSINLPAALPAQLRQARIGRDKIASTSD-VISQNGARTELLVPRGRMGTGKDGDEN---DLLGQGHATLTRLSW-LGHRTVDDAVMSALTG-------
177 UniRef50_B5JGB2 Survival protein SurE n=1 T... 189 1e-46 1 25.9% 2:229 3:249 -KILIVNDDGIDSPLLLALVSSFQRLGEVVVAAPRYEQSWVGKCMSRFKDVDVIERkpCEAYSISGSPADCVNLALGHLLHEKPLCVVSGINVGHNAgaYILSSGTVGAALEGALHDIPSFAASLGLDrdYdlAATLLTDFAEKTMVSGEPSyvVHKLNFPFAPIDKDTPIVRSNPA-RTEAGSFFTQT---GNAYSFTYRELAENAPAVPTDRDTLKAGHISYSRLDF------------------------
178 UniRef50_D1Z3R6 Whole genome shotgun sequen... 186 6e-46 1 26.0% 1:235 1:338 MHILVVNDDGpsSPYVHSLVRELQAAGHVvvCLPHTQRSWIGKAHMIGQTVKPLYYRPpeWILVDGTPASCVQIGLYHFFQDriDLVVSGPNYGRNtaVFALSSGTLGGALEAAVCKRRAIALSYafNRNHDpaSRQSVRVIEALWKEWPTDrdLYSVNVPLLEGLEEGKVLYTPMLQNYwhTHKHFKWSPRFTDVY-----KSVEEAAPGNDGWAVKEGHTSVTPLKANFWNTA------------------
179 UniRef50_B2GIE3 5'-nucleotidase SurE n=2 Ta... 185 1e-45 1 31.0% 1:229 9:245 MHILVTNDDGISSPGLAVLARAALERGhvKVAAPAEEYSGASASLslVPASPPEMPEDVECVGVKAAPALIAFLASYGAFGQRPDMILSGVNLGANTGKATLHSGTVGAVLTGASHGIPGIAVSigAPQHWDTALLVTRYALERWEQRPFDE-WILNVNVPDVSPDRLRGLKPARLASFGAVQAQIGRGDEKHIAVTYSAETGPE---EPESDHYLLTHGWATATLLRA------------------------
180 UniRef50_UPI000197BC91 acid phosphatase n=1 Tax=Pr... 185 1e-45 1 33.3% 1:225 25:270 MRILLVNDDGCDAFGITELKSQLDAKgdVWLVGPATNQSGIGTAITfgKEFDVKKVDERT-YCFPGTPADSLDFGLQGLLRepPDLVISGVNDGPNTGTSQLNSGTVSAAARAVRLGYPAIAASIgtHKYWPDSVTYVVELVDDLNKNwlPAKSGLSINYPALAKDKIKGIKFVE-NEYAVSPQILYEITPEGKAKQIINPEALKIRND-DSDTGYLDKGYITYT----------------------------
181 UniRef50_A2RAR0 Contig An18c0130, complete ... 184 2e-45 1 25.6% 1:238 1:317 MHILVVNDDGplSPYIEPLVTALESAGhiSVAIPAASRSWIGKAHLIEASLTATYvdNDWVIITNGTPASCVQLGLHNLFPDriDLVISGPNHGRNASTIYNLsgTVGGALEAATCGKRGIAISFGSKDeiHAAARLATRVVNHLIQNWDDQVELYNVNVPMRLDVESRPVLWTRTYPYYWARGYLYSehANgrNFAWAamKKALQESPEGTDAHTVLSGCTSVTALRANFWHVPGLE---------------
182 UniRef50_UPI0001746631 stationary phase survival p... 184 2e-45 1 29.7% 1:229 3:237 LHFLLTNDDGIEAPGLAALAAAVSAiaTYTIAAPDREYSQCGHRVTTTEVLKVLQKAE-HAYAVSGTPADCVRAAVFGL-GIKPDFVLSGVNAGGNMGQDLVISGTVAGAREAAYHGFRSAAFSHYLVkdWERTGRWTTQLIEWLLGQNLADGEFWNVNYPHLPPGslPERLITSPARPPMLVTYDRSEGNAGEWDLRYTARYADRPAPVGSDVNVCFGGAVSVSRLSV------------------------
183 UniRef50_Q84MD7 At1g72880 n=11 Tax=Embryoph... 184 3e-45 1 30.5% 3:245 63:378 --VLVTNGDGIDSPGLVSLVEAleGLYNVHVCAPQTDKSASAHSTTPGETIAVskLKGATAFEVSGTPVDCISLGLSGALfsKPILVISGINQGSSCGHQMFYSGAVAGGREALISGVPSLSISLNweSHFKDAVGVCLPliRDIAKGVFPKDCSLNIEIPTSPSSN-KGFKVTKqaNRHPggNFMSNQQSLGAQLAQLGRDASAAGAaeHTdvKALEDGFVSVTPFslPKTDSETQAAASEWIS--------
184 UniRef50_Q6CC87 YALI0C11495p n=1 Tax=Yarrow... 184 3e-45 1 24.6% 1:240 1:312 MHVLLTNDDGpySPYFHYLVKAIEKYthVTVVLPDTQRSWIGKAHMIGQTITATYIEAPewTLLNGTPATCTNIGLNYMIDepVDLVISGPNFGRNtaLYSTTSGTIGAAMEGALCGSKGIALSYAYYSrvAEASRLAVKLISKLYENWDKGVDLYSINVPLIEgsDNTKAVHAPILQNRWKGTFEppIEPDSEPlyTMFRWAPDFEasPGNDGWVVDQGHISVTGLKASFSETGITGEI-------------
185 UniRef50_A4R2M8 Putative uncharacterized pr... 184 3e-45 1 27.2% 1:232 1:329 MHILVVNDDGpsSPYVHTLVRALQGAGhvSVCLPHTQRSWIGKAHLIGQTVRPTYYRPpeWVLVDGTPASCVQIGLHHMFTdkVDLVLSGPNYGRntALFALSSGTLGGALEGAACKVPSIALSYAFfrNHDpaSRHAVRVVEALVKQWPQdvDLYSVNIPLVEGVEKARTLWTPMLQNYWAdeERIRQGAGGEAALSSGAQNGKAAAdpGNDGWAVKEGYTSVTPLKANFW---------------------
186 UniRef50_C1MYI8 Predicted protein n=1 Tax=M... 183 5e-45 1 37.6% 3:231 15:315 --VLVVNDDGIDAPGILALVRALANCgdVYVAAPDAERSACSHCISIHAPLAVEPRSIPGayAVSGTPADCAMLATGALFPsrFDFVVSGVNRGDNLGRHVIYSGTVAGAREGAMkgGVGVAVSLCSYsdYSDAASVAAETLTAVRStgALAGKVLNVNVPhgGGSGIKGVKLTRPGFSCTQPDWVRVSSPggGDAAWTKggPHTRDDGDGTDQRAIDDGYVSVSILSCEF----------------------
187 UniRef50_D1I2X1 Whole genome shotgun sequen... 183 5e-45 1 31.7% 3:182 44:238 --VLVTNGDGIESPGLTSLVQAlePRFHVHVCAPQSDKSVSGHSMTVQETLTaaEIGGATAYEVSGTPADCVSLALSGALFskPVLVICGINKGSSYGLNMFHSGAVAGAREALLCGVPALCISMNWKedFKDAVNVCLPiiRDIEKGIFPKSCLVNIEIPSSPLKN-KGFKVARQSLRRPA-----------------------------------------------------------------------
188 UniRef50_C1EEU3 Predicted protein n=1 Tax=M... 183 5e-45 1 35.0% 2:215 17:241 -NVLVVNDDGIAAAGLAKVVEALDRTgdVYVVAPDKEMSATSHSISIHNAVSATPrgATRAFSSSGTPADCTMLGLSVLYrkRFDYIVSGINRGDNLGLHVVYSGTVAGAREGAMrgAVGVAVSLDSYsdYSEAARLTAELVTSIHDAPglRGCVLNVNVPNLPRTHIKGVKLTTPGLSCTQAEWVRVPGTRGDSC---DDLNEDETRGPDSDSD--------------------------------------
189 UniRef50_B0NGY9 Putative uncharacterized pr... 182 1e-44 1 25.1% 1:231 1:253 MkiLITNDDGIHSPGLAAAACAAADLADILIVAPHTQQTGMARAFPRTEDAGIIEEeeVRGYGVHGSPALAVAHGVLELAERKPDLCISGVNYGENMGAVLTCSGTLGAAFEAVSHGIPTIAISLEAetDWDAAKRMLHSWISRVLDRGMPEYvlININMPA-GSGHPDEFRITSLSRQNYFEFIRPKARNLKEPFALKSRLSVDMDteRDSDIHAVYVDRisVTPINMNM----------------------
190 UniRef50_O83434 5'-nucleotidase surE n=2 Ta... 181 1e-44 1 40.9% 1:159 1:167 MRILLTNDDGYQAAGIRALHAALKAayEVTVVAPDRDRSAVSHGITTLEPVTVKEVE-PGIWSCSGTPVDCVNRALRQVcgTPPDVVVSGINEGENLGTDIVFSGTVAAARQAVMYGIAGIAASLLPVSdfQALARFVARHVRALAALS-SEDVLVNIN----------------------------------------------------------------------------------------------
191 UniRef50_C6H1G0 Tubulin-tyrosine ligase n=1... 181 3e-44 1 22.9% 3:233 443:759 --IRVVNDDGpsSPYVHPLVHTLESAGHVvvVLPHRQRSWIGKAhtYFRPGTLHKDDgnEWILIDSTPASCVQIGLFHYFKDriDLVISGPNYGRntAVFALSSGTLGGALEAAVCGYRSIALSYasSRDHDpaSRHSVRLIGHLYKNWEEDVDFYSINVPLEAGVSEAKILYTNVLDNRwhRHMHFKWAPKFSDVY-----KSVDLGPPGNDGWTVKEGMTSVTRLKANFMH--------------------
192 UniRef50_B9LSF3 Stationary-phase survival p... 179 6e-44 1 35.3% 3:220 5:260 --ILLTNDDGIDAVGIRALADALSRDYDVTVVAPASNQSGVGGARSWWDT-TVEYTETDAGYAVEGTPADCVAVA-DVALGLDPDVVVSGCNHGPNIGAHIlqSGTVGAAMEASFLGTPAIAVSLydNGDFAVAGEVVVDLLDRAETgsLpgADVLNVNVPAADDEAAAdyRLTEPARGFDVIEFHPGEapEgrDRFWREFLRGDVADDPGSDRLAAVEG---------------------------------
193 UniRef50_C9SJ06 TTL domain-containing prote... 179 1e-43 1 26.4% 1:231 1:270 MHILIVNDDGpsSPYFAPFLAALHAAGHtvVVIPDRPLSWIAKAHPVGKTLTATPYLPmhWLLVDGPPASCVQLGLFHTggSAFDLVISGPNHGRNSGahTLSSGTVGGALEAALCGRRAIALSFGSkrRTADACLRSCALVEELAREWAPGVELYSVNVPMVDSVTTCPARYTKVAANRWSkpEESQEDAKGTLRFRWAPDLADVHRsaGEDLWCSLNESISVTPLKADF----------------------
194 UniRef50_A6DQJ4 Predicted acid phosphatase ... 178 2e-43 1 23.7% 1:224 1:243 MKILVTNDDSQDSPLLEYLLDELKGLGDLQIVVPKEEQSWTGKSISRFEQleEIEISGVKTCVLSGRPADCVNFGVYHMGDEKPDLVISGINIGYNCGvyVMSSGTVGACIEANIAGVPAVSLSreTYQRWSNERCFSPEEIKQirADFLAEPITWQVEMPQDLSEDWS-LEAGHLGHSFYGSLFEQKSNG----AYGHSLKKHDLDSREKADVNIIARGNVSV-----------------------------
195 UniRef50_C1G129 TTL domain-containing prote... 177 3e-43 1 24.9% 1:181 417:639 MHILVVNDDGpsSPYVHSLVHTLQSSGhvSVVLPHRQRSWIGKAhtYFRPGTLHKDDgdEWILIDSTPASCVQIGLFHYFKDriDLVISGPNYGRNtaVFALSSGTIGGAMEAAMCGLKAIALSFasSRDHDpaSRHSVRLIGYVYENWGEDVDLYSINVPLEPGVSEGKVLYTDILQNRW------------------------------------------------------------------------
196 UniRef50_B0CQ21 Predicted protein n=2 Tax=A... 177 4e-43 1 23.0% 3:241 5:312 --VLLTNDDGpeSPYVLGLYLHLTrlgnVHVVLPSTQKSWIGKaiTRGNYFYPKEDGKGewILLDGTPATCANVALHNIFHEKIDLVISGPNLGRNTSsfALSSGTIGAAMSSSLSKIRSIALSYGTVVhfEPAHNLACRIIQHLWNNWGEDEclYSVNIPLVesEEGLKICWTRMWRNSYGRLFKNISTVNQDSiyTTSMPKNEGEepFGSDGWAIHNGWVSVTPLRASFGEPHIHDDID------------
197 UniRef50_Q0JJY1 Os01g0709400 protein n=6 Ta... 177 4e-43 1 29.5% 3:195 68:275 --VLLTCAGGIRAPGLAALVDSLVAGgdVHVCAPESDKPACGYSITIRETITATSVdgAKAFEISGTPVDCVSLALSGRLFsaPALVISGINAGANCGYEMFHSSAIAAAREALLYDVPSIAISLNWksDFKDAAEVCLPLieGVEKGTFLRGCLLNIGVPSSPTTN-KGFKLTKQSIYRPAQSWEGVSTSRPTP----------------------------------------------------------
198 UniRef50_C6WQS9 Survival protein SurE n=1 T... 176 4e-43 1 29.8% 1:228 1:233 MRALVTNDDGIDSPGLLALARGAREHgeVVVAAPEREASGTSAGLTahRSIHVERRdgFEAYAVAGHPGLIALVASRGGFGEVPDVVLSGVNRGANTGRAVLHSGTVGAVLTASVNDLRGMAVSLDVPLewDSAVTVARGLFDVLA--GLPDGAVLNVNAPNVA-DPGEPVRAT-LAEFGSVQTRVKRADEGTIDV---NSVLVPGDLPEGSDAALLVAGRATVTPLR-------------------------
199 UniRef50_D2Q361 Stationary-phase survival p... 175 1e-42 1 37.0% 1:227 4:232 LRVLITNDDGYQARGIRALATAIAAAGhvLVVAPLDDQSGVGSArlVDRPIRTTEETEDGITyvDGTPALAVTLARAGAFGPSPDVVASGINHGHNIGVPILHSGTVAAALTAATQGLSAIAVSLDspKHLDTAALVAARALDWLATE--PAGTVITVNVPDRPLDELEGVRRATLAP-IERSRITGGTAPTGEPM--IRLEPPAAAPSPDTDEALLAAGYVTVTPL--------------------------
200 UniRef50_B1ZS95 Stationary-phase survival p... 175 1e-42 1 30.0% 1:227 1:265 MRLLVTNDDGINSVFLHELVHALQAAGHVliAAPKREQSWVGAGKSRHRAVHCELVddCPTWIVDGTPSDCVNIALAHLldASPDlvVSGINVGLNASlfILASGTIAGAWEGALHGLPAVAFSQDMSTalKISARHAAALTPQLlaTPLRSFTVHNINFP-VAIRPDSEVRRTVPARVIVPGLFSPAADDGTHTFVFSHGEEMSVE-DALTDRAAVAAGYISHTTL--------------------------
201 UniRef50_D1BXY9 Survival protein SurE n=1 T... 175 1e-42 1 31.1% 1:235 1:250 MLALITNDDGIASPGLVVLARVAQAAgdVVIAAPKAESSGASAALhlDGRLMVEPAEPprAFAVSADPALITFSAAYGAFGARPDLVLSGVNRGPNVGNAVLYSGTVGAALAATSLGIRAVAVSLddPVHWDTAEQVAAHALAWFATVDAGRRT-LNVNVPDLPPGELRGLRQAPLASFGAVHARVVPADprGDDVV-IRYEGTERHTEPESDAGMLDAGWATATLLVAPWADTT------------------
202 UniRef50_C5DUD1 ZYRO0C15796p n=5 Tax=Saccha... 175 2e-42 1 23.3% 1:249 1:316 MRVLLTNDDGpfSPYVRPFVQHIRKNyeLTICIPHTQRSWIGKAHFAGKSLTAqsNDDIEWILIDGTPASCVNIGLHHLNSEPFDLVISGPNVGRNTSsyISSSGTVGAAMEAVISgtKAVALSFadSSVVDLAAQKSMEVINHLYHNWNDGTDLYTINVPLSTSLKptRIMWTSIWENRWRAIFE------GPDVAQLTNGSEIEDGVEgtDKDVIEAKMISVTPLRA------TFKKVEGLVGELSL----
203 UniRef50_B8N162 Putative uncharacterized pr... 175 2e-42 1 24.3% 13:238 84:365 ------------SPYIRPFVNALQDAGhvSVAIPAASRSWIGKAHLIEASLKATYVPppEWVVinGTPASCVQLGLFNLFQDRpdLVISGPNHGRNAStyNLSSGTVGGALEAATCSKRAIAISFGSKDPQPdaARHAVKVVNYLYEHWHADVELYNLNVPMREDVESRPVRWTEALPYYWpgEVTADKKVNGhdFTWAamKKTLQSSREGTDAHTVLNGDTSVTALRANFWHVPDLE---------------
204 UniRef50_Q8ZSY4 5'-nucleotidase surE2 n=5 T... 174 3e-42 1 28.1% 1:217 1:212 MKIVVTNDDGPHSPLLEPLVRGLEAVGnvVVVVPERPRSAAGLARTYHKPLRVRRLGG--YYVVNGFPADAVFLAL-KLIAPDAELVISGVNVGENIGIEATysGTVGAALQAGVLGVPSIAASMEVGGDVDFMIKVVEGAVAS-ARAGLDGVLAVSINIPSVWKGGVYCVR--KLARAVYRERLYEGVDPRGEKYYWRWG-PRRSEFEPDTDAYYF------------------------------------
205 UniRef50_Q18E70 Acid phosphatase n=2 Tax=Ha... 173 4e-42 1 31.7% 3:229 8:263 --ILLTNDDGIDAPGLATLRTELTALGNVTVVAPESNQSGVGRTRNPTAIVR----DHPWGCALTGTPADCVAYGLRGL-DTNIDIVVAGVNNGPNAGNYVvrSGTVGAGIEAAFLGTPALAISAYHStdFARPARIARRLVDRALSAgyDDVDLLNVNAPVDTAN--PPVMLTDPYHDYEQEVEQASADdqLRDRTWPGVVGWESPFPpgTDRRALVDAAVSVSPLSV------------------------
206 UniRef50_C7Z590 Putative uncharacterized pr... 171 2e-41 1 25.1% 1:235 1:288 MHVLVTNDDGpaSPYVSCLIQQLKGAGH--TVSPLYYrsSVIHgtTHHRPSPSGDVE--EWILIDGTPASCVQIGLHHFFQDriDLVVSGPNYGRNtaVFALSSGTLGAALEAAVCQKKAIALSFAFFTriEAACRRSVKVIEALYKQWPTdaDLYSVNVPLVEGLENKKAIWTNMLQNYWRehKHFKWAPRFTDVY-----KSVEESKPGNDGWAVKEGLTSVTALKANFMHDS------------------
207 UniRef50_A3IZH6 Glycerophosphodiester phosp... 171 2e-41 1 29.1% 1:227 306:556 LEILLVNDDGFEAEGINVLFEGLKAAgdVTLVAPKEQQSGRGTLINVDkpTEVVNFEPNKWF-VDGSPIVTTLAGLDYILDEEPDLVISGINEGANIGEnvISSGTVSAATTATRRGIPSIAVSAGGNtaYEEGTALIIDIIETLEAQRLPEAEllNINIPGTFAEGVNGIQGVVLTELDEISNLEFSFGeeGAGVLviTPSEVENEMSEGENFLA---GFMTITPI--------------------------
208 UniRef50_P38254 TTL domain-containing prote... 170 4e-41 1 20.2% 1:252 1:325 MRVLITNDDGpfSPYIRPFIQHIKRNykITVCVPHVQKSWVGKAHLAGKNLTAqpKDTIEWILIDGTPASCANIGLHLLSNEPFDLVLSGPNVGRNTsaYITSSGTVGGAMESVITgtKAIAISWasPLLMEKASKRSLDVIKHLVKNWDPKTDLYSINIPLVEssDDTKVYYAPIWENRweNSFAEIEDGNEssFNwiHYMDEYKDRTVLTDAEVIESEMISVTPMKA------TFKGVNHLLGELKLTEE-
209 UniRef50_C5JQM9 Acid phosphatase n=4 Tax=On... 168 1e-40 1 25.2% 1:238 1:343 MHILVVNDDGpcSPYLFPFVKTLEKAGhvSVVIPNSSRSWIGKAHIIGETLEATYISppWVVVNNGTPAACTQLGIYSLFPDriDLVISGPNHGRNAS--IIysGTVGGALEAATCGKKAIALSFASKEkiQAASRLSVKLIERLSAHWPDERvlFSINVPMRLDVEERPAVYTNMLPNSwgGDDDQRIPPQQARYFKWAPELSdeASKVGTDTYTVMNGWTSVTPLAANFSHVSGFS---------------
210 UniRef50_C4Y1P2 Putative uncharacterized pr... 168 1e-40 1 22.5% 1:231 1:275 MHVLLTNDDGPPspFMKPFVDEIRRSTnvSVVVPNQQRSWIGKAHFAGKKVAANYieYQEWVLLDSTPAACADIGLHHvhSEPVDLVVSGPNFGKNSGryILASGTVGAAMEAVTHGTKAVALSYedPETVREACRVSVRLVARLYrqKQPDVDLFSVNVPLVPSLSltPVKYAPVLCNAWESMYSEewTPDFEQVWRDGLADKRH-----SDSRVLADDGISVTPLRAEF----------------------
211 UniRef50_Q7UF93 Acid phosphatase SurE n=1 T... 167 2e-40 1 37.2% 3:166 14:204 --ILLTNDDGIDAPGLVAMHQAiqDRYDITVVAPDRGRSECGHSVTTTRDLAVTEVQS-GWFAVDGTPVDCVRSAMTVLCPNA-SLVFSGINAGANLGVDLLVSGTFAAAREAALHGVPSMAVSHYRRPdwDHTGRWLKPVLDSFFREVMspGQLWNVNLPAIDPD---------------------------------------------------------------------------------------
212 UniRef50_Q9YDW8 5'-nucleotidase surE n=1 Ta... 167 3e-40 1 26.5% 1:245 2:256 LKAIVTNDDGVHSRSLRALAESLASRgdVVVAAPLGNWSGYSKSIGRFRGNRVYRFESRGVRFFTGDMPPAALVGTadIAGFEPDIVVSGINYGPNLgyDFFSSGTIGGALEAALRGFKSVSISSACREelPEALSISLAVVETSVETLSSSAGLMVVNIPRSP----RGFKVTRPCRRVP--RFSGEIGEEGSLLVEKFDHSRLFSSEHDsdGRLFSMGYIPVspL--DPSRDGYLKAVEDILN--------
213 UniRef50_Q2GKI2 Stationary-phase survival p... 167 4e-40 1 28.6% 24:240 10:232 -----------------------QAFSEVWISAPARNCSGMSRSISVGVPVEARKVNDRE-YTISGTPVDSAVLGLhsVAGVLPDLVLSGINYGSNVGSKVLYSGTIAAAAAAASMGIPSIAISqgTDINWGNSEKVVLDIVKQLMDDpwDRKSVMSINVPHF---DILGMHFTEQGDYCPCGDVADAPGEEPdtIYTICDVNRETKLeqKASSEMLRAGYIIVTPVGSDLTDHSTLNRM-------------
214 UniRef50_A4T4H1 Exopolyphosphatase / 5'-nuc... 167 4e-40 1 28.8% 4:246 10:259 ---LITNDDGIDSVGLHVLAGAAIKAgdVIVAAPAEqqDGR----TVVER-RELPDLDVEAWAVQAQPGHIVAAALNGWFDPRPDLVLSGINHGANVGRAILHSGTVGAALTAKISDTRALAVSLngERYWETAAGLIAPVLDLLLEA--PDGTVLSLNVPDRPADEVGPIRPARLAPGGAVQTKVEEVRDGG---VRLTEVEVPDKPDADTDSALLDAGHPTLTELRSVEADDGDL--VHRWLEG-------
215 UniRef50_B9WFM4 Tubulin tyrosine ligase, pu... 166 8e-40 1 24.2% 1:231 1:290 MHVLLTNDDGpsCPYFKYLVDEIITTTDwsIVVPDQQRSWIGKAHFAGKTLSASYieYQEWCLINSTPAACADIGIHHLynKPVDLVISGPNFGKNSSnyILASGTVGAAMEAVTHGVKSIALSYAFnhDykEAAKISVKLIKKLYQQLQSSsdLFSINIPLVDSLNLESTKitPLLETNEKGQLQFSWTPDFKKVYKDGLADKNH-----TDSRVLLEEGISVTPLQAAF----------------------
216 UniRef50_C3K8C6 Putative stationary-phase s... 162 6e-39 1 27.9% 1:226 21:280 LNILLSNDDGYQHPNIRALYTQLKAQGhvKIAAPQSDQSARGGAFFFGREVTVGHDTDPAyyYIsgTPVMALLMGLDKVL-PHPDLVIVGPNPGNNLGAINMASGTFNAASVALQSGIPALAVSTdkEQDPQRAAQLVAKLVDTLDRHrlPPGLGLNMNLPK--GTQIKGVKLTRVGSyrYSDDL-KQFNLPGKPGIGFQYSPAATAAQQNDEAVWLNKGYLTISP---------------------------
217 UniRef50_O23348 Putative uncharacterized pr... 162 7e-39 1 32.1% 3:167 16:238 --IMVTNDDGIDAPGLRSLVRVltNLYDVRVCAPdrEKSAVSHSIIWSRPLTAKRVegATAYSVDGTPADCTGLGLSelFPSRPDLVLSGINVGSNCGYNmvYSGTVAGAREAFLYDVPSASISYDFdnDFALSAQACLPIINGIlnKTHPMQCFLNIDLPTDIANH--------------------------------------------------------------------------------------
218 UniRef50_B4G027 Acid phosphatase n=9 Tax=Sp... 162 7e-39 1 28.9% 3:192 70:274 --VLLTCAGGIRSAGLAALVDALVAAgdVHVCAPESDKQACGHSITIRETIAASSVdgAKAFETSGTPVDCVSLALSGRLFpsPALVISGINTGSNCGYEMFHSSAIAAAREALVYGVPSIAISLNWksDFKDAAQACLPLINAALDdtFLRGCLLNIGVPSAPSAN-KGFKLTKQSGYSPAQSWEAVSTSR-------------------------------------------------------------
219 UniRef50_Q4P3P7 Putative uncharacterized pr... 159 9e-38 1 26.0% 1:231 70:395 LKVLLVNDDGpsSPHVLGLYEELCALgeVSVVLPSFQKSWGSMQFSlrRPINRERGEIAEWILIDGSPTTASNAGlnAFFGDTpdLVVSGPNFGRNTGtfALSSGTVGAAMAASLAGVRSIAVSFgnPPTFatANKLSASLIQRLYDNWapDVGCYSINIPLCETISQPQVIWTRIWENRYGPLFAAEStpKPQNVLHFAPNMapTTLPEGTDVWAILNGYVSITRLRPNF----------------------
220 UniRef50_C5GBJ4 Acid phosphatase n=1 Tax=Aj... 158 2e-37 1 24.5% 6:238 79:416 -----VNDDGpcSPYLFPFVKTLEKAGhvSVVIPNSSRSWIGKAHIIGETLEATYISppWVVVNNGTPAACTQLGIYSLFPDriDLVISGPNHGRNAS--IIysGTVGGALEAATCGKKAIALSFASKEkiQAASRLSVKLIERLSAHWPDERvlFSINVPMRLDVEERPAVYTNMLPNSwgGDDDQRIPPQLARYFKWAPELSdeASKVGTDTYTVMNGWTSVTPLAANFSHVSGFS---------------
221 UniRef50_C9PGF2 Acid phosphatase stationary... 157 3e-37 1 26.9% 1:227 26:312 LNILLTNDDSWETTNIQVMKSTLEAAGhvIMSAPCTGQSGKGGAMTFLKPVSVDETQSADQEYceGTPVMAATYGIdaVWGQDPDLVISGPNEGNNLGYMNNNSGTLGAAMISLSRGIPAIAVSANSNTASDavANVVVKIVAQLVANqlPAYTGLNVNTPE-EMNSTMGYKFTDVGWNGGGALLKFSDDLSTDsyYTmgGMTSEedTSEDSEGIAVNEGYITISTI--------------------------
222 UniRef50_B7H2T6 5'-nucleotidase surE(Nucleo... 157 3e-37 1 25.3% 1:245 21:313 LNILLVNDDGLTS-NIKALYDELKANGhvLVSVPCSPQSGRGGAIVMYSSTTItgYTNGDWNYTHGTPVMATVYGLDVVAPKrpDLVLSGPNEGQNVGKVVVHSGTIGNVQFSAGRGIPSIALSAdsNPNSAIVAKQTVVLLKELQAKalPKGITLNVNFPKNLTTS-TPFAFSKIGTYdyKLKFQVTKDNKGNNQFGLgaAPSAPTAAQMSDESAVMQSKIAVTAMQV---AYDQRPPAQEWLK--------
223 UniRef50_A5DII9 Putative uncharacterized pr... 156 8e-37 1 21.4% 3:245 22:319 --ILLSNDDGWASTYIRAAYRDLKDAgnVILVAPVSQRSGYGGKFDVPtpSWDHEKDDQNIWYFNGTPASCISFALDYLLPEkpDLVVAGPNEGPNLSPGFYtsGTMGAVYNAIYRGIPAISFSGSDFNnfKDssKKVVELTKKVIDGGMPAITGINVNFPKvpSCDDPKWQFGrmGKGVFVQNMKYNSDSGLMEWGTKYFDNISKDCDSGddIYLKNNCSTSVSVFTVDytTLSTSNTVKKLLG--------
224 UniRef50_B6QKV6 Acid phosphatase, putative ... 155 1e-36 1 24.6% 40:238 108:335 ---------------------------------------ASSEHLNVSTPDDQNENEEDYWAVinGTPASCAQLGLYELFPNriDLVISGPNHGRNAStyNLSSGTVGGALEAATCGKRGIALSFGSKDeiAAAARLSTRVIEHLWRNWDERVELYNLNVPMREDVESRPVRYTRALRNEWteIQQKGKSNRIRQFQWSTekRSLAESPQGTDARTVLDGFTSVTPLKANFWHPDGFS---------------
225 UniRef50_C4R6Y8 Putative tubulin tyrosine l... 154 3e-36 1 23.0% 1:191 1:234 MHVLLINDDGpsSPYAKFLVDAIRNHTDwsIVVPSQQRSWIGKAHFAGKELTAQYLYsqEWVLIDGTPASCTDIGVHHLYKDKpdLVLSGPNYGRntALYIMASGTLGGALEGALTGKRAIGLSYSFyrDHDaaSELSLKLIKYLYNNWHPEAELYSINVpkDSLGPDTKAIFAPILENRWGSVFTKVIES--------------------------------------------------------------
226 UniRef50_UPI0001908C8F stationary phase survival p... 152 9e-36 1 33.3% 97:252 1:160 ------------------------------------------------------------------------------------------------VADDVTYSGTIAGAIEGTMQGVRSFALSQAyyEdwEVCETHAPALLEKLMVLDLPEGTFLNLNFPNCRPDEVDGAEVTMQGKLAFNLQVDARSDGRGFPYYWLKFGERAGAFIEGTDIHALKHNKISVTPLKLDLTDYSVTDRVARAL---GYGAQ-
227 UniRef50_A2R979 Similarity to hypothetical ... 152 1e-35 1 25.0% 1:188 1:236 MHILVVNDDGpgSPFVHSLVNELKAQGhvTVVLPNRQRSWIGKAHFVGEIVRPTYYYPDrwVLVNSTPAGCVQIGLYHShpNPVDLVISGPNLGANTTtfSLSSGTIGGALEAALCGKRSIALSFEPPSKLpeASRHSVRLINYLYHNWDEGVELYSINVPLQPATTAAGERKVMYSRIRPNRWLSES-----------------------------------------------------------------
228 UniRef50_B5EV17 Acid phosphatase n=2 Tax=Ga... 150 4e-35 1 27.3% 1:227 25:312 LNIVLTNDDSWNTNNIQAMKSALIEQGhvIMSAPCTGQSGKGGAINFFKAVNVDTTQSAkeYCveGTPVMSVLYGIDVAAQErpDLVVSGPNEGNNLGYMNNNSGTLGATMIALSRNIPAIAVSGSENSAQDsiAKVVVDVINNLEKTrlPAYTGLNINTPHDIDNNL-GYLYTNVGWNAGGIELKFVSDLSNNEmyVVnmAGDAGDTDEMSEGVAVKSGYITISTI--------------------------
229 UniRef50_Q9SSN8 F3N23.8 protein n=1 Tax=Ara... 150 4e-35 1 25.5% 3:245 63:352 --VLVTNGDGIDSPGLVSLVEalEGLYNVHVCAPQTDKSASAHSTTPGETIAVskLKGATAFEVSGTPVDCISLGLSGALfsKPILVISGINQGSSCGHQMKKNES--------------------QESHFKDAVGVCLPliRDIAKGVFPKDCSLNIEIPTSPSSN-KGFKVTKqaNRHPggNFMSNQQSLGAQLAQLGRDASAAGAaeHTdvKALEDGFVSVTPFslPKTDSETQAAASEWIS--------
230 UniRef50_C9STC1 TTL domain-containing prote... 149 1e-34 1 28.8% 1:153 1:198 MHILVTNDDGpsSPYVASLVAELKKAGhvSVCLPHTQRSWIGKAHIIGQSVKPVYYTPseWVLVDGTPASCVQIGLHHFFAErvDLVVSGPNYGRNtaVFALSSGTLGGAMEGAICGKKAIALSYafSRNHDpaARHGVRVIEKLYADCPPTP----------------------------------------------------------------------------------------------------
231 UniRef50_Q2UK26 Predicted acid phosphatase ... 146 7e-34 1 22.8% 46:238 11:236 ---------------------------------------------TLETTFPDTETQPEWVVIRNGTPASCVQLGLFNLFQDRpdLVISGPNHGRNAStyNLSSGTVGGALEAATCSKRAIAISFGSKDPQPdaARHAVKVVNYLYEHWHADVELYNLNVPMREDVESRPVRWTEALPYYWPrtADKKVNGHTEpfTWAamKKTLQSSREGTDAHTVLNGDTSVTALRANFWHVPDLE---------------
232 UniRef50_C7BLP0 5'-nucleotidase SurE (Nucle... 146 7e-34 1 29.2% 1:168 1:173 MKIVIVNDDGYEEPFHHDFVDHLKKLadVISVTPSKNMSGFASAINIRNYVQFTEYESQM-YKVDGTSVDCALIglANYFWGKPDLLVSGINRGMNYGPCVIYSGTYAAARESSRQGILAVSFSANenRRILDSATL---ILEKILSDKFdkNAVLNVNFNSVLSDKL-------------------------------------------------------------------------------------
233 UniRef50_C4YC48 Putative uncharacterized pr... 145 1e-33 1 27.9% 3:167 36:246 --ILLTNDDGWAATNIRAAYRDLKNAgnVVMVAPVSQRSGFGGQFNIPppSWGHEEDDLNIWYFNGTPASCVAFAVNYVFPttIDLVVAGPNEGTNLSPGMYtsGTIGATYSAVGRGIPGIAFSgnGNNSfdDVAryARKVVEMvhPNLLPLTTGINVNFPPTGDED--------------------------------------------------------------------------------------
234 UniRef50_C5MD31 Putative uncharacterized pr... 144 3e-33 1 26.1% 2:177 21:244 -NILMSNDDGWATANIRAFYYKLKEAGhvYIVAPVTDMSGHGGQFDLPepMYGHEVDDDHVFYFNGTPASCVAFAFDYILPttIDMVVAGNNYAQNYGGYFSLSGTMGATIEAVYRGYPAIAFSAWSWNnyKdvAEKATELVNQIFESQGENpvGLNVNFPAVGYDNEScwVFTRIA----------------------------------------------------------------------------
235 UniRef50_D1VKF7 Survival protein SurE n=1 T... 142 1e-32 1 28.0% 3:227 60:283 --ILVSNDDGVGAAGIDAVVTALRALPAVTvvAPATNQSGTGGKTSPTTPAhaTTASGVAATAVDGFPADSVNVALD-VLGVKPNLVVTGINQGQNLGPFVDLSGTVGAARAAAAHGIPALATSMGLGpdYSQAATLVTAWVTAHRagGAALSTVTNLNIPNCGAAKIRGER-----------ELATEPTVTDMATAITNGQDCSSTANPADEVGAFNAGFATLTTI--------------------------
236 UniRef50_B9W8D0 Acid phosphatase,, putative... 141 3e-32 1 27.9% 2:180 20:247 -NILLTNDDGWQATNIRATYYKLKEAGhvFLVAPVSQRSGFSGKFDIPtpSWGHEVDDDHIWYFNGTPASSAVFGINYVIPntIDLVVSGPNEGTNMSPGLFtsGTVGATYTSIYRGIPGVAfsLDLKDDKEPSTIYANKIVEFVTqrALGLGVGLNVNFPKVGYENEtkWVFTRLTGQY-------------------------------------------------------------------------
237 UniRef50_Q0K3N3 Predicted acid phosphatase ... 140 4e-32 1 26.5% 2:231 31:308 -NILLTNDDGCAAPGITAVRKALQDAGhvITVGPATNQSGSGAAYAVPdpLavHRVKATFvyLGSGSPVDATAMGLKIVGPetPDLVVSGANFGENLSDSIPHSGTVMNVLFAARRGVPGIALSVGVdaAFPRAGAFLARVIASLEATrlPVAHPLSINYPIAAGGTPAGVRLTTPGTVDSFTTAYKRNADNTVSIDVGAPETEAAALARIAETPAFLAKFITISALDVDF----------------------
238 UniRef50_Q5KPW3 Cytoplasm protein, putative... 139 6e-32 1 22.2% 3:209 13:285 --VLLTNDDGpsSPNIYAFCKLLqrLgdVRVVIPDCQKSWVGKSynYFYPLelKEGESMEWVLLSGTPATCANIALHNIYPGQIDLVISGPNHGRNSStfALSSGTLGATLAASLshMPCIAISYgsDRVLELATETAVDVCQQLFDNWGEDKEvySINIPLVEakNERKIVSTEMWRNAYGRLFKTTkdPGDDPVQIAHGYMKSQDKP--------------------------------------------
239 UniRef50_B3T6I5 Putative uncharacterized pr... 139 9e-32 1 34.4% 117:241 1:129 --------------------------------------------------------------------------------------------------------------------GAPSIAFSQIYDDnwATAEKWAGRVLKKLTAELWPTGVLINVNFPDVTARRVTGIEITRQGRRKIGSDMARGTDPRGEPYYWIGAQRREEPYRRGTDLEAVRRGAVSVTPLTMDLTHAPTLKKMK------------
240 UniRef50_UPI00016ABAA1 stationary phase survival p... 136 7e-31 1 47.8% 133:245 2:114 ------------------------------------------------------------------------------------------------------------------------------------DAARVAAEIVRHYLDHPLPGQPLLNVNIPNLPYEELKGWRVTRLGKRHPSQPVIRQTNPRGEPIYWIGAAGDALDASEGTDFHATASGYVSITPLQLDLTHTQMLAATRDWAR--------
241 UniRef50_P30887 Acid phosphatase n=3 Tax=Ya... 136 9e-31 1 27.7% 3:179 44:268 --IVVTNDDSWASANIRAFYDELKKEgnVFMFAPALQQSGTGGTFVLPKNTTLAkeKDDHIWYFDGTPGAAVTFGFDYALPktVDLVVSGPNEGWNLGPFVYtsGTEGAMYTSVLRGVPAIAFSGEnhTYYANaaKASTAIVKNLLKNalPYGVGLSVNLPLVGDIDPTGKcfTRQTGR--------------------------------------------------------------------------
242 UniRef50_Q2GSR6 Putative uncharacterized pr... 131 2e-29 1 25.3% 54:231 119:347 -----------------------------------------------------TRRGTEEWILVDGTPASCVQIGLYHFFRDrvDLVVSGPNYGRntAVFALSSGTLGGALEAAVCKHRAVALSYafSRNHDtaTRQGVRVIEALVRDWPAdvDLYSVNVPLLEGLEKGKVLYTPMLQNYwhTHKHFKWSPRFTDVY-----QSVEEAPPGNDGWAVKEGHTSVTPLKANF----------------------
243 UniRef50_Q0CEG2 Putative uncharacterized pr... 130 4e-29 1 25.9% 2:171 16:218 -NIISSNDDGWAEKNIRTLYDSLTTAGhvVISAPAENQSGKGSRDEPPSNLTeyNASQPHWNYVNSYPVTSMKHGIQTlfGGVPDLAVAGPNVGANIGLAVFLSGTVGATTYAAhaKIPAIAFSgeSTPAYSTiaDLAAKVTDRLVAAglPEDIWLNVNFPRVTDSSCTSV----------------------------------------------------------------------------------
244 UniRef50_B2WGN4 Acid phosphatase n=3 Tax=Le... 130 4e-29 1 24.0% 1:233 22:303 LKILMGNDDGFGSGNLRELYKLLVGAGhvLIVAPAQQQSGKGTtlTVPSQYNIVPAgdDNIWYYDGTPAACTFVALDYVLpqTADLFIAGPNYGTNLGPFVmlSGTVGATIAAVSRSIPGFATSASNkpYFNVTgkVTFDIVNEFIKNtlPLGYGVNINLPELANGTMPPVVKSRLTGQ--ANTDVAVFNETTGLFTWDNVDPVagDTSLPGETWVVGGGSISVSAFTLDWSA--------------------
245 UniRef50_B8N5N1 Acid phosphatase, putative ... 129 9e-29 1 26.5% 2:163 18:229 -NIISANDDGWAEKNIRTLYDTLTADGhvVISAPAENKSGTGmsPLLTQPLTLdnATQPRWNYVNSYPVTSIKYGIQNlfNGKPDLAVTGPNVGANLGVANAISGTVGAACYAAhaGIPAIAFSGSSGsaWDDpaQLATKVVDKVVAAglPEDVYLNVNFPKV------------------------------------------------------------------------------------------
246 UniRef50_B8PDE4 Predicted protein n=1 Tax=P... 126 5e-28 1 34.6% 3:132 24:176 --VLLTNDDGWADAQIRAQYDElrAVFNVVLSSPSENQSGTG-STTATPTVLTEPCenPRINYVNAYPVDAAYYGIETlfGKKPDFVVSGPNIGNNLGTVVLESGTVGAACEAAKLGVPSTAFSGdqPSDYK-------------------------------------------------------------------------------------------------------------------------
247 UniRef50_UPI0000382485 COG0496: Predicted acid pho... 126 1e-27 1 27.4% 111:245 1:142 --------------------------------------------------------------------------------------------------------------MEGTILGVRSIALSQagSLKWACAAEHGPQVIRKILEIGIEPGILINVNFPDCEPGEVKGVAVSAQGQRNQAlqIDARHDGRGNPYFWLAFAKARFEPGNGSDLKAIADNRISVTPLRLDLTDEPELTRFAKAFE--------
248 UniRef50_D1NC77 Acid phosphatase surE n=2 T... 124 3e-27 1 50.0% 153:246 20:113 --------------------------------------------------------------------------------------------------------------------------------------------------------RVIININVPDLPFEELKGYKVCRLGYRASSAEVIKQKDPRDETIYWIGPSALPEDESEGTDFYAVKNGYVSITPIQADLTAYHSLLSLQNWLDQ-------
249 UniRef50_B6H014 Pc12g13590 protein n=14 Tax... 121 2e-26 1 23.6% 2:166 17:214 -NIISSNDDGWAEANIRAFFEFLQAADhvVVSAPAENQSGKGSktVLTEPCQFNScsESRLGYVNSYPVTAIKYGIekFFNGAPDLAVTGPNVGSNIDIVNYFSGTVGAATYAAQNGIPALAFssGSPTSWDSpaDLATNLTNQVIAAglPDDIFLNVNFGKVTDE---------------------------------------------------------------------------------------
250 UniRef50_Q4P1L8 Putative uncharacterized pr... 120 4e-26 1 23.9% 1:197 114:365 LNIVLTNDDSWASANVRALYYALRRAGhvLMVSPSHNQSGKGGTVVLPTELNItnVSDPGLRYFNGTPAACSGWALDHDAQYFfdLVVSGPNEGTNLGPFLYtsGTIGASYFAVERGVPSIAISASTDIRQYTsaTYSANFVTTVSDEalPLGIGLTVNYPkvPTGNCTDLTwtRLTGKAIVDRFVVNAT-TGLPTY--------------------------------------------------------
251 UniRef50_Q5SLD2 Survival protein SurE n=1 T... 110 4e-23 1 40.4% 155:248 2:91 ----------------------------------------------------------------------------------------------------------------------------------------------------------LLNVNFPAS---RPKGLLVTRLSTHRFEDQVVERLDPEGKPYYWIAGTP-AGEEEEGTDLWAVRRGYVSVTPVSLDLTAHGFLEALSGLLEGVA-----
252 UniRef50_A8KYH3 Survival protein SurE n=1 T... 105 2e-21 1 26.6% 40:227 56:242 ---------------------------------------GGGGKTTMPTPThaATAGGITATAVDGFPADAVTVALD-VLRLTPDLVVSGINQGQNLGPVVDLSGTVGAARAAASRGVPAIASSMGTGddFAPAVKLVTDWvsAGAPSSGPRATIANLNIPNCAA-----------GGRIRGERELPTQPALPDLAVALAPQDCTSSAEPGEEVAAFTAGFATLTEI--------------------------
253 UniRef50_A2R311 Putative frameshift n=1 Tax... 97 7e-19 1 25.0% 54:169 62:195 -----------------------------------------------------HNSSQPRFNYVNSYPATSMKYGLNNlfSGSPDLAVAGPNVGANLGLAVFFSGTVGATTYAANQGIPAIAFSGYTGsaWNVsaELATKLVDELVESglPEGVWLNVNFGAVSDDSCT------------------------------------------------------------------------------------
254 UniRef50_UPI00019070CB stationary phase survival p... 92 2e-17 1 40.8% 1:76 1:80 MKVLLTNDDGYQSPGVAAARDALIACgqVLTVAPDGPRSGTSRSASFRKAITMTKAGGDDvyVTNGTPTDCVRVAV---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
255 UniRef50_Q5K891 Cytoplasm protein, putative... 84 4e-15 1 19.0% 7:195 39:241 ------NDDGpsSPNIFSFAKTLQalgdVRVVIPDSQKSWC-----VAPPL-------PRAWTPDSPptGSAR-------------------HGRNSStfALSSGTIGAALAATleHVPCIALSYapPRLLALAAETSVDVCKRLFDNWGHDSviYSVNVPLVEEYLEKgaVYTELWKNAYGRLFKphFDPGDDP----------------------------------------------------------
256 UniRef50_UPI000187DF26 hypothetical protein MPER_0... 67 6e-10 1 29.6% 2:82 33:133 -RILLTNDDGWATGAIRAQYEALRDAgqIILSAPAVDRSGTG-PLSADPVVVVDGCedARINYVNAFPADSVKFGIRTLAPK---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
257 UniRef50_A8IEK5 Predicted protein (Fragment... 64 4e-09 1 22.0% 75:192 10:140 --------------------------------------------------------------------------GLLRALDLHPIMALSGPNYGPNMGTDVLLRWTLTEMALSTLEGRPaiVTGGLGRRHVHSSCdwVMDVEQVLVDAFQDGDVFINLNVPA-QWQRGHGVQTTGLGLMFYRDSYVVSVPGR-------------------------------------------------------------
258 UniRef50_B8PJW6 Predicted protein n=1 Tax=P... 58 3e-07 1 23.7% 3:95 24:103 --ILLTNDDGLVVAQISAQYRgmSFRGQVW--------NGVQNYYTHTR-----------VNYVNAYPVDAANYGIkkFFTKEPDFVDSGPNIGN--------------------------------------------------------------------------------------------------------------------------------------------------------------
259 UniRef50_Q4FTW0 Putative uncharacterized pr... 46 0.001 1 37.8% 58:94 30:67 ---------------------------------------------------------PSGFIAVNGTPADGIYLALNELYPedFDCVITGINSG---------------------------------------------------------------------------------------------------------------------------------------------------------------
260 UniRef50_A9SJL0 Predicted protein n=1 Tax=P... 44 0.004 1 28.6% 186:248 46:110 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ESDKEPSPRMRFRLEGAEQELGaePDHDFGALQQGYVSITALGLD-THVEAtaQVEKWVAGVA-----
261 UniRef50_A3LSW4 Acid phosphatase-like prote... 40 0.080 1 15.8% 58:171 145:290 ---------------------------------------------------------DANIWYVNSTPLNSLRVAFDVILPevPDVVIVGPNEGSSLTTSPEHTgtNLEAlaSLTKNITTVGIsfQDEKYFKIQanFINRKISQLLQgdLSKPVAVNVNFPSMNHESSRCI----------------------------------------------------------------------------------
262 UniRef50_A0LKB8 Glycosyl transferase, group... 40 0.095 1 17.9% 102:185 300:386 -----------------------------------------------------------------------------------------------------LYEGTANAMLEAMVMGLPVVAFDIPAVHEFCPSETIVCPFAdkGLAQGLDRCLTLLSTTPtcPSPAFRQALVAKFSSRRWHQEL--------------------------------------------------------------------
consensus/100% .............................................................................................................................................................................................................................................................
consensus/90% ...h.sNDDG..t..h..h...h....ph.h.hP....oh.u.th.....h..........h.htutPsssh.huh..h.....shhluG.N.G.N.u.....SGThuushtu...th.uhuhS......ht....h...hht.h.........hhslNhP.........h..s.........................................................................
consensus/80% ..lLlsNDDGh.u.tl..hhp.htthtplhlssPttppSuhutshsh.tsh.h..ht...hh.hsGoPssss.huh..hh....DlllSG.N.G.Nhu..hhhSGTluuAhpuhh.sh.ulAhSh....pht.stthhhtlht.hhtt.h....hhslNhP.....t.t.hhhs..s.......h....t.....hh.............tsD..hh.tthhslo.h...................
consensus/70% .plLloNDDGhtu.GltsLhpthpthucVhlsAPtpppSuhupuhohtpslphpphtt.thhhlsGTPsDClhlulttlhttpsDlVlSGlNhGtNhu.phhhSGTluAAhEushhGlsulAhShst.tpap.usphshpllptlhtt.hstshhhNlNhPth..tp.pshthsp.utthhtt.h..t.sspsp.hhhht......t.t.ssDh.hl.pshlolTPlth................
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown